Non-rheumatic valve diseases

I9_NONRHEVALV

heart valve disease: A disease involving the cardial valve.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I34, I35, I36, I37 Hospital discharge: ICD-9 — 424 Hospital discharge: ICD-8 — 39[4-6]\|424 Hospital discharge: excluded ICD-8 — 4249\|3940\|3950\|3960\|3970 Cause of death: ICD-10 — I34, I35, I36, I37 Cause of death: ICD-9 — 424 Cause of death: ICD-8 — 39[4-6]\|424 Cause of death: excluded ICD-8 — 4249\|3940\|3950\|3960\|3970 2 out of 7 registries used, show all original rules.	31589
4. Check minimum number of events None	31589
5. Include endpoints None	31589
6. Filter based on genotype QC (FinnGen only)	30612

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_NONRHEVALV
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I3[4-7]
HD_ICD_9	424
HD_ICD_8	39[4-6]\|424
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	4249\|3940\|3950\|3960\|3970
COD_MAINONLY
COD_ICD_10	I3[4-7]
COD_ICD_9	424
COD_ICD_8	39[4-6]\|424
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	4249\|3940\|3950\|3960\|3970
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-rheumatic valve diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	215676	107164	106544
Only index persons	175595	87966	87629
Unadjusted period prevalence (%)
Whole population	3.01	3.07	2.98
Only index persons	3.29	3.23	3.35
Median age at first event (years)
Whole population	71.82	74.38	69.26
Only index persons	71.28	73.70	68.86

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30612	13255	17357
Unadjusted period prevalence (%)	6.54	4.70	7.95
Median age at first event (years)	69.71	70.10	69.42

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25163: Matched controls
181504

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.6

315.3

688

903

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.9

314.5

1745

4593

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

314.3

2870

9647

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

313.3

1694

4394

I20.09

ICD-10 Finland

Unstable angina

3.1

312.8

1484

3565

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

311.2

3977

15282

I97.0

ICD-10 Finland

Postcardiotomy syndrome

35.4

310.9

253

TK800

NOMESCO Finland

Hemodialysis

5.6

309.0

680

900

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

203.5

307.7

2898

116

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

21.1

307.7

591

207

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

353.3

307.7

8288

252

B01AB05

ATC

enoxaparin; parenteral

2.1

307.7

8684

36341

I44.0

ICD-10 Finland

Atrioventricular block, first degree

16.6

307.7

419

185

C01BC04

ATC

flecainide; systemic

99.5

307.7

1032

K83

ICPC

Heart valve disease NOS

204.1

307.7

1161

WX872

NOMESCO Finland

Intensive care

9.7

307.7

3073

2559

I42.0

ICD-10 Finland

Dilated cardiomyopathy

917.9

307.7

979

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

68.3

307.7

428

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

11.8

307.7

877

555

XFE00

NOMESCO Finland

Epicardial ultrasonography

12.4

307.7

1127

681

I35.0

ICD-10 Finland

Aortic (valve) stenosis

315.4

307.7

9056

323

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

232.1

307.7

1626

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

666.5

307.7

543

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

5.8

307.7

1963

2614

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

15.6

307.7

13721

12954

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

258.0

307.7

491

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

5.6

307.7

3051

4368

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

307.7

3252

9053

I35.8

ICD-10 Finland

Other aortic valve disorders

69.9

307.7

382

SPAT1263

SPAT

Sampling

1.8

307.7

9786

48356

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

30.1

307.7

1402

355

B01AA03

ATC

warfarin; systemic

17.7

307.7

10595

7167

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

28.8

307.7

525

134

I50

ICD-10 Finland

Heart failure

31.3

307.7

1200

290

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

35.2

307.7

437

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

24.2

307.7

465

141

I48

ICD-10 Finland

Atrial fibrillation and flutter

206.2

307.7

9715

552

205

Kela drug reimbursment

Chronic hypertension

1.9

307.7

7311

31527

K84

ICPC

Heart disease other

8.8

307.7

1201

1026

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

307.7

4877

15340

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1309.8

307.7

372

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.5

307.7

2850

6417

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

307.7

2400

6726

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

572.2

307.7

391

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

307.7

1021

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.0

307.7

1068

1599

I48.1

ICD-10 Finland

Persistent atrial fibrillation

300.8

307.7

1674

M10.9

ICD-10 Finland

Gout, unspecified

2.9

307.7

1852

4884

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

20.3

307.7

5148

2271

C01BD01

ATC

amiodarone; systemic

260.9

307.7

1336

250, ,

Kela drug reimbursment

127.0

307.7

551

C09DX04

ATC

valsartan and sacubitril; oral

1367.0

307.7

359

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

54.8

307.7

367

I49.1

ICD-10 Finland

Atrial premature depolarization

8.5

307.7

854

745

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

8726.9

307.7

1162

GD1LA

NOMESCO Finland

45.0

307.7

484

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

307.7

7344

32901

C03DA01

ATC

spironolactone; oral

6.3

307.7

4693

6335

C09AA05

ATC

ramipril; oral

2.8

307.7

7876

25335

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

11.5

307.7

10127

10004

AB2

AVR bio, stent

+∞

307.7

586

XF640, ,

NOMESCO Finland

16.4

307.7

1518

709

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.5

307.7

1641

3510

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

2937.7

307.7

408

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

824.1

307.7

1504

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

3.0

307.7

5577

15880

I47.1

ICD-10 Finland

Supraventricular tachycardia

36.4

307.7

1087

225

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

2347.5

307.7

649

K78

ICPC

Atrial fibrillation/flutter

33.1

307.7

3202

795

B01AF03

ATC

edoxaban; oral

21.9

307.7

633

214

C10AA05

ATC

atorvastatin; oral

2.0

307.7

11567

54486

B01AF01

ATC

rivaroxaban; oral

2.8

307.7

3207

9099

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

143.2

307.7

236

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

307.7

6553

29188

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

307.7

1732

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

569.3

307.7

3353

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

86.0

307.7

1577

141

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

540.5

307.7

6422

115

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

6345

26019

R06.0

ICD-10 Finland

Dyspnoea

3.0

307.7

7980

24507

I34.1

ICD-10 Finland

Mitral (valve) prolapse

337.2

307.7

4240

109

I50.9

ICD-10 Finland

Heart failure, unspecified

91.8

307.7

6708

716

B01AF02

ATC

apixaban; oral

12.7

307.7

4371

2961

FL1AC

NOMESCO Finland

Left cardioangiography

6.8

307.7

617

666

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2026.1

307.7

2527

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

7435

29426

K80

ICPC

Cardiac arrhythmia NOS

3.8

307.7

1960

3948

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

172.9

307.7

2170

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

307.7

373

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

646.4

307.7

1595

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.6

307.7

2820

4835

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

307.7

2781

7556

WW502

NOMESCO Finland

Autotransfusion

14.5

307.7

372

187

K77

ICPC

Heart failure

25.4

307.7

791

232

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.0

307.7

6881

12816

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

158.9

307.7

2889

148

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.2

307.7

1638

2419

C07AA07

ATC

sotalol; systemic

10.0

307.7

1221

924

R00.1

ICD-10 Finland

Bradycardia, unspecified

7.3

307.7

916

939

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.5

307.7

5456

17893

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

7.7

307.7

11145

17082

AA1AD

NOMESCO Finland

CT of head and brain

2.3

307.7

7503

28761

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

307.7

3986

12641

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

307.7

412

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

321.5

307.7

609

B01AE07

ATC

dabigatran etexilate; oral

7.3

307.7

1014

1045

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

114.5

307.7

859

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

307.7

2380

4430

C01DA14

ATC

isosorbide mononitrate; oral

3.5

307.7

5019

12098

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

307.7

1938

4309

R02

ICPC

Shortness of breath/dyspnoea

2.5

307.7

3303

10495

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.7

307.7

1585

3242

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

7.6

307.7

1680

1699

C08CA01

ATC

amlodipine; oral

1.8

307.7

10041

48565

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

307.7

385

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

307.7

3635

9552

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

307.7

8264

38850

WX892

NOMESCO Finland

Monitored bed care

3.5

307.7

2239

4873

TFP20

NOMESCO Finland

Cardiodefibrillation

288.9

307.7

3487

101

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

79.1

307.7

735

XF404

NOMESCO Finland

Ambulatory ECG

11.7

307.7

3589

2539

I44.1

ICD-10 Finland

Atrioventricular block, second degree

130.4

307.7

600

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

7.4

307.7

1787

1850

AB1

AVR mechanical

1328.3

307.7

377

AS4

Physiological pacemaker insertion DDD (R)

506.5

307.7

415

I25.2

ICD-10 Finland

Old myocardial infarction

3.8

307.7

1833

3706

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

307.7

4380

13475

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

21.1

307.7

306

106

Angiography of the heart and coronary arteries

4.5

307.7

2006

3410

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

6.5

307.7

771

878

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

20.6

307.7

2419

932

M04AA01

ATC

allopurinol; systemic

2.7

307.7

3748

11105

C03CA01

ATC

furosemide; systemic

6.3

307.7

11899

22632

K99

ICPC

Cardiovascular disease other

7.6

307.7

974

960

SPAT1097

SPAT

Recording of ECG

2.3

307.7

3890

13226

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

7.8

307.7

1171

1127

AC4

MVP

+∞

307.7

458

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

4.1

307.7

1086

1971

C07AB02

ATC

metoprolol; systemic

2.8

307.7

5844

17983

AN1

Coronary angiography

5.5

307.7

4571

7065

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

452.1

307.7

3081

201

Kela drug reimbursment

Chronic cardiac insufficiency

22.4

307.7

2393

848

C08DA01

ATC

verapamil; systemic

4.8

307.7

1010

1576

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

10.4

307.7

634

448

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

737.6

307.7

793

R55

ICD-10 Finland

Syncope and collapse

2.4

307.7

2785

9103

Q23.11

ICD-10 Finland

Bicuspid aortic valve

117.0

307.7

1102

TFP34

NOMESCO Finland

Electrophysiological investigation

331.7

307.7

930

C01AA05

ATC

digoxin; systemic

29.0

307.7

3445

988

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.2

307.7

8289

19146

Catheterization and pressure measurement of the right side of the heart

85.7

307.7

247

R04.0

ICD-10 Finland

Epistaxis

3.2

307.7

2222

5328

207

Kela drug reimbursment

Chronic arrhythmias

372.6

307.7

6683

176

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.0

307.7

2084

5334

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

26.3

307.7

399

111

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

307.7

477

AP1

Catheterization of the left side of the heart

8.2

307.7

547

492

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

86.2

307.7

1185

104

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.4

307.7

2032

3542

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

133.2

307.7

328

I49.3

ICD-10 Finland

Ventricular premature depolarization

13.5

307.7

2177

1268

I50.1

ICD-10 Finland

Left ventricular failure

1287.9

307.7

2274

ZXD05

NOMESCO Finland

Urgent procedure

2.1

307.7

7454

30303

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

11.9

307.7

5120

3823

B01AC04

ATC

clopidogrel; oral

2.4

307.7

4787

16052

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

307.7

7485

30972

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

307.7

1606

3478

Catheterization and pressure measurement of the left side of the heart

7.1

307.7

607

633

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

307.7

14975

52439

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.7

307.7

1652

3418

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

307.7

5656

21621

C10AA01

ATC

simvastatin; oral

1.9

307.7

11570

56534

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

473.6

307.7

764

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1011.2

307.7

6539

I47.2

ICD-10 Finland

Ventricular tachycardia

185.7

307.7

701

I49.5

ICD-10 Finland

Sick sinus syndrome

297.9

307.7

1293

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

307.7

16437

85012

XF402

NOMESCO Finland

ECG with work load test

4.3

307.7

3820

7327

PD5BD

NOMESCO Finland

Extensive CT of aorta

11.6

307.7

1011

654

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

63.2

307.7

320

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

23.9

307.7

3430

1189

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

307.7

603

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

226.0

307.7

3177

116

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

15.7

307.7

865

410

I50.0

ICD-10 Finland

Congestive heart failure

213.4

307.7

3537

139

I48.2

ICD-10 Finland

Chronic atrial fibrillation

736.3

307.7

2062

PD5AD

NOMESCO Finland

CT of aorta

9.1

307.7

1049

866

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3940.5

307.7

542

C07AB07

ATC

bisoprolol; oral

6.2

307.7

17068

46309

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

5804

I44.2

ICD-10 Finland

Atrioventricular block, complete

4089.3

307.7

1100

N02BE01

ATC

paracetamol; systemic, rectal

2.1

307.7

21673

136284

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

307.7

2098

5635

AA1

Conventional CABG

6.9

307.7

687

738

TFP35

NOMESCO Finland

Electroanatomical mapping

363.5

307.7

398

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.0

307.7

7836

23497

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

307.7

1113

I35

ICD-10 Finland

Nonrheumatic aortic valve disorders

151.3

307.0

208

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

502.3

305.1

344

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

303.5

2784

9369

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1255.0

300.7

333

FM1DE, ,

SPAT

24.1

300.0

271

A02BC02

ATC

pantoprazole; systemic

1.7

299.8

16267

94774

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

298.0

325

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

8.4

297.3

458

401

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

12.6

296.6

352

204

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

293.2

3336

12246

AP3

Catheterization of the right and left side of the heart

83.6

291.5

207

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

289.7

5365

23321

AP2

Catheterization of the right side of the heart

54.4

289.3

217

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

277.6

729

1137

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

6.6

276.8

515

570

C10AX09

ATC

ezetimibe; oral

1.9

276.4

4089

16486

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

274.1

299

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

273.7

1949

5829

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

273.1

6853

32482

UJF32

NOMESCO Finland

Coloscopy

1.7

270.7

6433

30018

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.8

270.0

936

1822

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

269.9

3241

12118

I48.3

ICD-10 Finland

Typical atrial flutter

372.6

269.7

307

J01CA04

ATC

amoxicillin; systemic

1.7

269.3

18927

116122

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

443.0

268.6

304

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

267.2

1054

2246

I45.9

ICD-10 Finland

Conduction disorder, unspecified

50.6

266.2

202

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

265.4

8878

45317

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

+∞

264.9

289

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.0

264.4

420

383

C08DB01

ATC

diltiazem; oral

3.0

263.6

1321

3273

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

263.1

649

957

A12BA01

ATC

potassium chloride; oral

3.4

262.7

1061

2297

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

262.6

1265

3061

R42

ICD-10 Finland

Dizziness and giddiness

1.8

259.8

5361

23974

C09AA02

ATC

enalapril; systemic

1.8

258.6

4868

21172

FXZ00

NOMESCO Finland

Off-pump cardiac operation

13.2

258.5

299

165

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

257.6

281

A46

ICD-10 Finland

Erysipelas

2.0

257.3

3483

13587

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

256.7

280

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

115.6

253.6

175

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

250.2

2105

6794

SPAT1301

SPAT

No procedures

1.7

249.8

7281

35755

SPAT1325

SPAT

Vaccination

1.6

249.8

7951

39934

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.9

248.6

621

926

ZXE00

NOMESCO Finland

One hour or less

1.6

246.5

8716

44896

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

246.3

1628

4686

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

244.4

2524

8880

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.3

244.0

1046

2353

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.6

244.0

1638

4751

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.9

243.6

607

903

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

6.3

242.6

470

544

C09CA01

ATC

losartan; oral

1.7

242.1

6311

30048

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

64.3

241.6

177

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

239.4

2481

8738

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

93.3

237.7

167

K05

ICPC

Irregular heartbeat other

4.3

237.1

690

1173

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

236.7

1826

5661

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

235.5

257

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

+∞

234.6

256

AQ1

Conventional electrophysiological examination

222.6

234.3

273

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.3

233.4

993

2222

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

44.8

230.9

179

H02AB06

ATC

prednisolone; systemic

1.6

230.9

10868

59584

A28

ICPC

Limited function/disability NOS

1.8

230.2

3969

16731

FM1AD

NOMESCO Finland

CT of heart

34.0

227.6

187

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.1

226.3

714

1294

PD5CD

NOMESCO Finland

Very extensive CT angiography of aorta

12.2

221.7

267

159

S97

ICPC

Chronic ulcer skin

2.6

221.0

1454

4170

A11CC03

ATC

alfacalcidol; systemic

4.3

219.8

637

1079

342

Kela drug reimbursment

Dronedarone

+∞

219.0

239

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.9

217.8

1160

2971

R53

ICD-10 Finland

Malaise and fatigue

1.7

215.3

4916

22469

K29

ICPC

Cardiovascular sympt/complt other

2.9

213.5

1113

2816

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.8

211.6

729

1411

N19

ICD-10 Finland

Unspecified kidney failure

3.4

210.1

863

1886

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

1630.1

209.3

231

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

207.4

907

2064

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

4.5

207.3

572

930

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

206.4

9304

50132

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.4

206.4

395

451

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

58.4

206.1

153

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

286.3

206.1

237

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

21.7

204.3

191

K04

ICPC

Palpitations/awareness of heart

3.0

204.1

1037

2584

R00.2

ICD-10 Finland

Palpitations

2.5

203.3

1445

4301

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

415.8

202.0

229

S18

ICPC

Laceration/cut

1.5

201.3

10653

59313

R4110

NOMESCO Finland

Physiotherapy

1.6

200.4

6362

31581

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

199.7

218

C07AG02

ATC

carvedilol; oral

2.5

199.3

1463

4421

C07AB03

ATC

atenolol; systemic

2.5

197.2

1374

4049

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

209.3

195.9

229

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

27.4

195.8

170

C08CA02

ATC

felodipine; oral

2.0

195.6

2347

8712

Q25.1

ICD-10 Finland

Coarctation of aorta

31.8

194.0

162

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

528.0

193.6

218

SPAT1254

SPAT

Administration of medicine

1.8

189.8

3232

13503

WX402

NOMESCO Finland

General anaesthesia

1.7

189.4

4715

21966

C01BA03

ATC

disopyramide; systemic

25.4

189.2

168

1CX08, ,

NOMESCO Finland

49.7

189.2

144

XF622

NOMESCO Finland

Measurement of minute volume of heart

19.7

188.2

182

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

188.0

1481

4622

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.2

187.2

842

1949

SPAT1260

SPAT

Consultation of another employee

1.7

185.9

4000

17899

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

18.0

185.7

186

C01BD07

ATC

dronedarone; oral

+∞

185.0

202

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.7

184.6

1134

3134

C01BA01

ATC

quinidine; oral

28.0

183.0

158

A40.8

ICD-10 Finland

Other streptococcal sepsis

7.1

182.8

318

325

R50.9

ICD-10 Finland

Fever, unspecified

1.8

182.8

3285

13942

AS2

Ventricular pacemaker insertion VVI (R)

302.8

182.2

209

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

7.6

181.5

301

290

R31

ICD-10 Finland

Unspecified haematuria

2.0

180.0

2446

9479

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

179.5

8548

46228

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

178.6

195

I45.3

ICD-10 Finland

Trifascicular block

90.6

177.3

125

K92.1

ICD-10 Finland

Melaena

2.5

177.3

1306

3949

Z2221

NOMESCO Finland

Medical doctor

1.6

176.0

5749

28584

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

175.9

9546

52962

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

711.9

175.4

196

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

175.3

649

1321

J01DB01

ATC

cefalexin; oral

1.5

174.8

19041

121235

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

173.7

1409

4452

3A064, ,

NOMESCO Finland

25.4

173.4

154

N02AX02

ATC

tramadol; systemic, rectal

1.5

171.7

9947

55826

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

171.3

7680

40916

C08CA13

ATC

lercanidipine; oral

1.8

170.5

3379

14738

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.5

170.0

1204

3571

C03AA03

ATC

hydrochlorothiazide; oral

2.0

168.0

2144

8117

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

167.9

1399

4472

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

166.7

2890

12106

I20.00

ICD-10 Finland

Unstable angina

3.3

166.6

700

1551

Electrophysiological Special Examination

63.2

166.1

122

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

165.7

1148

3368

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

165.4

2992

12694

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

164.9

180

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

164.6

8964

49580

SPAT1310

SPAT

Counselling related to known health issue

1.5

164.4

6922

36322

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

164.3

2596

10560

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

163.2

6179

31678

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

162.5

5449

27180

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

162.0

3309

14541

AJ2

Reconstruction of the ascending aorta

47.3

161.5

124

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

1344.4

160.8

178

SPAT1153

SPAT

Removal of sutures

1.5

159.4

7291

38875

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.6

157.1

590

1213

WX002

NOMESCO Finland

Sedation and analgesia

1.6

156.6

4397

21001

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.5

156.3

429

694

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

156.2

7916

43048

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

16.7

155.7

161

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002030) Lymphocytes/100 leukocytes in Blood

12278

65784

1.68

323.31

7.3

6.1

24.96

28.30

183.17

11535

61238

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1872

5053

2.81

322.53

4.0

2.5

0.64

0.68

5.23

1867

5034

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3642

13370

2.13

322.40

4.2

3.0

—

(3018010) Neutrophils/100 leukocytes in Blood

12105

64769

1.67

318.53

7.0

5.9

59.50

56.63

116.00

11352

60233

(3018405) Lactate [Moles/volume] in Arterial blood

1597

3982

3.02

316.40

5.4

3.8

1.34

1.35

mmol/l

0.20

1572

3917

(3016502) Oxygen saturation in Arterial blood

4597

11779

3.22

307.65

10.1

6.8

95.83

96.12

1.96

4450

11348

(3013512) EKG study

9090

40005

2.00

307.65

6.0

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7054

31541

1.85

307.65

1.7

1.5

20.15

20.84

nmol/l

2.33

6001

26447

(3014007) Fractional oxyhemoglobin in Arterial blood

2939

7386

3.12

307.65

11.3

8.2

94.05

94.36

1.55

2929

7365

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22256

141201

2.19

307.65

23.7

12.2

27.18

25.23

mg/l

14.29

19331

109081

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1457

3248

3.37

307.65

3.4

2.5

3.35

3.61

g/l

7.51

1403

3113

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12685

46996

2.91

307.65

5.1

2.6

65.98

55.64

ng/l

0.41

10142

31919

(40760892) CBC W Ordered Manual Differential panel - Blood

12584

63427

1.86

307.65

7.6

6.3

—

(3020891) Body temperature

1825

4529

3.06

307.65

6.2

4.3

—

(3019069) Monocytes/100 leukocytes in Blood

12152

64033

1.71

307.65

7.5

6.3

9.08

8.67

34.81

11414

59411

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5945

15288

3.36

307.65

3.4

2.2

20.97

23.89

39.28

5100

12901

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5410

14289

3.21

307.65

3.9

4.5

266.21

239.99

u/l

21.52

5135

13472

(3019198) Lymphocytes [#/volume] in Blood

13343

69469

1.82

307.65

6.9

5.8

1.80

1.96

e9/l

5.58

11880

60643

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6009

19709

2.58

307.65

3.9

3.5

0.83

0.81

mmol/l

13.03

5637

18292

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4977

7796

5.49

307.65

3.8

1.8

278.56

78.84

ng/l

123.21

4708

6905

(3006504) Eosinophils/100 leukocytes in Blood

12102

63640

1.72

307.65

7.2

6.0

2.84

2.94

4.84

11341

58950

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13485

62662

2.19

307.65

9.2

5.2

1.19

1.22

mmol/l

199.16

12390

56412

(3014111) Lactate [Moles/volume] in Serum or Plasma

3472

10205

2.69

307.65

9.7

6.2

1.31

1.34

mmol/l

1.10

3399

9926

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1848

4572

3.07

307.65

2.2

1.9

1.84

2.36

ug/l

1.23

1614

4036

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2453

6499

2.91

307.65

13.7

8.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

349

139

18.35

307.65

9.2

7.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1388

156

67.87

307.65

3.3

1.8

0.81

0.88

nmol/l

0.38

1088

(3031040) Bacteria [#/volume] in Urine by Automated count

16187

91757

1.76

307.65

5.3

4.2

730.19

1334.69

e6/l

1.16

232

1308

(3001604) Monocytes [#/volume] in Blood

13141

67477

1.85

307.65

6.8

5.8

0.62

0.59

e9/l

25.96

11514

57584

(3004119) Hemoglobin [Mass/volume] in Venous blood

2620

6818

2.98

307.65

5.1

2.8

121.78

129.91

g/l

49.82

2546

6682

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15338

28623

8.34

307.65

4.3

1.8

1825.20

506.04

ng/l

168.49

14098

22920

(3006315) Basophils [#/volume] in Blood

13183

67650

1.85

307.65

6.8

5.8

0.04

e9/l

1.64

11554

57693

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2817

7199

3.05

307.65

9.9

6.2

24.55

24.67

mmol/l

0.84

2710

6814

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3955

12944

2.43

307.65

1.9

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

12566

59995

2.02

307.65

6.0

4.6

34.49

35.66

g/l

90.66

11664

55414

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11475

51014

2.14

307.65

3.7

2.5

166.85

147.04

ug/l

1.92

10547

46573

(3002032) Base excess in Venous blood by calculation

3642

10711

2.70

307.65

5.3

3.5

1.70

1.78

mmol/l

0.64

3141

9041

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2123

2896

5.68

307.65

5.0

2.6

0.33

0.35

u/ml

1.30

1357

1532

(3013826) Glucose [Moles/volume] in Serum or Plasma

16781

79807

2.55

307.65

7.2

4.0

6.79

6.75

mmol/l

1.56

16086

74258

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3637

10733

2.69

307.65

5.3

3.5

5.81

5.76

kpa

1.76

3545

10430

(3019060) Gas panel - Arterial blood

3008

7428

3.18

307.65

6.7

4.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10031

40588

2.30

307.65

2.5

2.0

233.37

210.58

u/l

1.92

9433

37735

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7294

18470

3.60

307.65

2.7

1.9

30.75

29.03

75.65

7112

17969

(3018418) pH of Serum or Plasma

8719

40518

1.84

307.65

5.5

3.7

7.40

2.17

2002

7315

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1919

5144

2.83

307.65

4.0

2.5

1.20

1.28

2.88

1912

5116

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13090

64789

1.95

307.65

3.2

2.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5629

19205

2.44

307.65

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3946

12991

2.41

307.65

1.9

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

9321

43685

1.86

307.65

3.0

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

17732

104212

1.77

307.65

5.1

3.9

15.08

11.93

mm/h

109.55

16376

95437

(3042936) Bacteria identified in Isolate by Culture

4714

18294

2.06

307.65

2.3

1.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2889

7343

3.08

307.65

11.4

8.1

0.66

0.69

4.50

2879

7298

(3013650) Neutrophils [#/volume] in Blood by Automated count

14620

79187

1.79

307.65

9.6

9.4

4.30

4.04

e9/l

31.82

12885

68569

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2489

4932

3.93

307.65

1.8

1.6

1.43

1.59

g/l

11.67

2019

4190

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6454

26648

2.00

307.65

2.2

1.6

1.32

1.31

mg/l

0.09

4968

20664

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8773

30545

2.65

307.65

2.7

2.1

3.30

2.82

mg/l

48.27

7688

25534

(3023520) Reticulocytes [#/volume] in Blood

3876

10299

3.03

307.65

2.9

2.6

72.01

67.30

e9/l

9.90

3011

7755

(3027945) Reticulocytes/100 erythrocytes in Blood

5078

13811

3.07

307.65

2.7

2.5

1.85

1.69

17.16

4575

12084

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

19117

110068

2.05

307.65

9.2

7.3

80.80

79.29

u/l

3.07

18153

102996

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7065

22503

2.76

307.65

5.2

2.7

1249.79

434.58

ng/l

7.93

6374

16961

(3000991) Gas panel - Venous blood

3474

9758

2.82

307.65

11.1

7.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

16682

58056

4.18

307.65

35.7

5.5

1.63

1.10

inr

322.10

5133

15868

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6149

16426

3.25

307.65

3.4

2.1

2.31

2.32

g/l

0.99

5777

14998

(3027801) Oxygen [Partial pressure] in Arterial blood

4894

13365

3.04

307.65

9.8

6.4

12.48

12.95

kpa

5.35

4691

12749

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

395

159

18.19

307.65

9.5

6.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

3012

8898

2.64

307.65

4.3

3.0

4.62

4.58

kpa

0.27

2929

8609

(3024928) Oxygen saturation in Venous blood

1131

2024

4.17

307.65

5.2

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

6527

17907

3.20

307.65

3.4

2.1

11.92

13.63

umol/l

58.82

6125

16514

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4225

11009

3.13

307.65

10.6

7.1

115.43

122.60

g/l

81.44

4136

10682

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1960

5374

2.77

307.65

5.9

4.1

23.86

24.05

mmol/l

1.79

1917

5255

(3044889) 12 lead EKG panel

17951

99141

2.07

307.65

6.3

3.1

—

(3022096) Basophils/100 leukocytes in Blood

11797

61640

1.72

307.65

7.2

6.0

0.67

0.69

3.47

11048

56981

(3003396) Base excess in Arterial blood by calculation

4901

13352

3.05

307.65

9.8

6.4

1.09

0.92

mmol/l

2.11

4063

10625

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2900

7368

3.08

307.65

11.1

8.1

1.37

1.35

0.45

2886

7321

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14837

71381

2.22

307.65

6.7

6.4

13.43

11.35

umol/l

49.30

14121

67537

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4899

13373

3.04

307.65

9.8

6.4

5.06

5.10

kpa

2.31

4706

12760

(3020779) Urea [Moles/volume] in Serum or Plasma

4363

10049

3.58

307.65

9.9

6.1

11.03

8.68

mmol/l

67.97

4170

9540

(3020630) Protein [Mass/volume] in Serum or Plasma

3264

10559

2.41

307.65

2.6

2.7

65.69

67.07

g/l

17.83

2988

9536

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4867

16198

2.45

307.65

8.5

5.0

1.09

1.01

mmol/l

49.68

4550

15043

(3023368) Bacteria identified in Blood by Culture

9286

34855

2.46

307.65

5.6

3.8

—

(3012544) pH of Venous blood

3952

11076

2.87

307.65

5.5

3.4

7.38

7.39

0.50

(3019309) Folate [Moles/volume] in Red Blood Cells

6088

25545

1.95

307.65

1.9

1.7

1260.76

1128.19

nmol/l

19.46

4644

18814

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7521

33253

1.90

307.65

2.9

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5187

8586

5.23

307.65

2.7

1.9

12.62

5.91

ug/l

53.79

4746

7262

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14542

69158

2.22

307.65

10.1

5.8

1.20

1.22

mmol/l

200.91

12197

58419

(3013115) Eosinophils [#/volume] in Blood

13498

69899

1.85

307.65

7.0

6.0

0.20

e9/l

1.01

11919

60413

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2674

7290

2.84

307.65

9.9

6.4

24.64

24.72

mmol/l

0.55

2653

7228

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2183

6198

2.69

307.65

12.2

8.3

24.29

24.22

mmol/l

0.44

2103

6025

(3026008) Bacteria identified in Urine by Culture

8371

41109

1.70

298.65

3.5

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8658

42988

1.69

295.92

2.8

2.5

60.07

64.25

u/l

1.28

7962

39314

(3043409) Potassium [Moles/volume] in Arterial blood

1411

3443

3.07

289.37

5.8

4.0

4.02

3.84

mmol/l

30.07

1402

3415

(3000850) Epithelial cells [#/volume] in Urine

6293

28756

1.77

287.79

3.1

2.5

4.66

5.16

e6/l

2.33

5715

25564

(3037467) Urinalysis macro (dipstick) panel - Urine

16482

96935

1.66

285.03

5.2

4.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7464

36036

1.70

279.34

3.4

2.5

3511.28

5139.52

umol/l

3.04

6441

31328

(3006576) Bicarbonate [Moles/volume] in Blood

380

282

9.85

276.58

8.1

4.7

25.25

24.76

mmol/l

1.17

333

261

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17240

102920

1.66

276.53

4.3

3.8

15.22

14.80

pmol/l

77.20

15475

91955

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10956

58555

1.62

275.04

2.2

1.9

94.82

95.84

pmol/l

1.30

5843

29510

(3004588) Protein electrophoresis panel - Serum or Plasma

2608

8912

2.24

272.66

2.5

2.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

267

104

18.71

270.26

7.8

6.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1895

5677

2.52

264.96

4.6

2.8

25.13

25.22

mmol/l

0.54

1840

5526

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8586

43526

1.64

263.22

3.4

3.3

35.82

34.11

u/l

1.11

8165

41062

(3003434) Protein [Mass/volume] in Pleural fluid

734

1205

4.50

263.22

1.6

1.3

28.29

38.32

g/l

66.81

648

1126

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20356

127858

1.78

260.02

5.3

4.4

2.04

2.15

mu/l

1.23

18476

114936

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1170

2717

3.21

259.74

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2339

7821

2.28

256.66

4.9

3.3

5.12

kpa

0.19

2214

7364

(3009343) pH of Capillary blood

2314

7726

2.28

254.70

4.9

3.3

7.41

7.42

1.64

401

838

(3010421) pH of Blood

1211

2907

3.11

254.64

5.1

3.3

7.42

0.56

1118

2672

(3030467) Casts [#/volume] in Urine by Automated count

7804

38894

1.65

253.59

3.8

3.0

0.52

0.39

e6/l

4.18

6254

29134

(3027315) Oxygen [Partial pressure] in Blood

1104

2510

3.27

253.38

5.1

3.3

8.39

8.71

kpa

5.88

1083

2449

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2250

7447

2.30

252.64

4.8

3.3

2.05

1.47

mmol/l

9.25

1667

5534

(3019550) Sodium [Moles/volume] in Serum or Plasma

22914

149925

2.15

252.44

30.0

13.5

139.35

139.73

mmol/l

86.95

22535

145448

(40767503) Oxygen content in Capillary blood by calculation

1034

2297

3.34

245.94

2.9

2.2

15.64

16.86

13.04

539

1182

(3013290) Carbon dioxide [Partial pressure] in Blood

1088

2506

3.23

244.50

5.1

3.3

4.94

4.99

kpa

1.13

1067

2446

(3012501) Base excess in Blood by calculation

1087

2506

3.22

243.91

5.1

3.3

2.61

2.40

mmol/l

1.39

746

1680

(3002582) Erythrocytes [#/volume] in Urine

8308

42390

1.62

243.48

3.9

3.1

111.26

74.17

e6/l

0.89

6673

32029

(3023103) Potassium [Moles/volume] in Serum or Plasma

22923

150384

2.12

242.41

30.3

13.6

4.02

3.97

mmol/l

167.33

22515

145612

(3033658) Prothrombin time (PT) actual/Normal

7152

35305

1.64

238.11

5.3

3.7

76.86

94.29

307.65

6995

34433

(36304419) Bacteria [Presence] in Urine

7520

37595

1.63

238.08

3.7

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

12146

68007

1.56

237.30

4.6

3.5

0.00

estimate

0.14

2743

13160

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2630

9523

2.11

236.32

5.2

3.4

114.53

79.65

ng/l

40.15

2263

8153

(3018095) Leukocytes [#/volume] in Urine

9340

49300

1.58

235.56

4.4

3.5

102.40

98.74

e6/l

0.12

7107

34453

(3007853) Bacteria identified in Skin by Aerobe culture

3667

14983

1.90

234.77

2.0

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1685

5059

2.50

233.64

7.6

4.3

1.72

1.63

2.42

1593

4743

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1340

3581

2.79

233.31

4.0

2.1

86.67

91.86

12.03

1310

3429

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1402

3852

2.72

231.76

3.4

51.55

39.34

mg/l

1.38

1094

3175

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2488

8886

2.13

231.33

1.8

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1403

3863

2.72

230.97

3.4

57.28

71.33

mg/l

0.33

1098

3179

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1724

5273

2.46

229.80

5.0

3.3

49.16

47.57

1.66

1709

5219

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1371

3740

2.74

229.67

3.3

10.04

3.33

ratio

0.63

328

(3036489) Thrombin time

1514

4377

2.59

226.56

2.9

1.9

22.95

21.12

12.41

1366

3826

(3007930) Methemoglobin/Hemoglobin.total in Blood

1648

4985

2.48

224.73

7.8

4.3

0.91

0.90

0.15

1556

4670

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2011

6708

2.26

220.55

1.5

1.4

—

(3021589) Normoblasts [#/volume] in Blood

11100

61594

1.54

219.47

14.0

8.8

0.00

e9/l

0.03

9360

50220

(3026782) Osmolality of Urine

5824

27756

1.67

218.94

3.5

2.7

516.55

558.29

mosm/kgh2o

42.22

5045

23609

(3009261) Glucose [Presence] in Urine by Test strip

12182

69017

1.53

218.57

4.6

3.5

0.00

estimate

0.78

2514

11976

(1616796) Gas panel - Central venous blood

1015

2417

3.11

215.78

4.9

3.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

762

1502

3.74

215.66

7.9

5.6

12.00

11.52

mg/l

1.93

699

1386

(3021601) Nitrite [Presence] in Urine by Test strip

12023

68219

1.52

211.50

5.9

4.7

0.00

estimate

0.02

2598

12278

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1209

3227

2.79

210.59

3.1

2.4

197.26

190.75

1.59

1159

3068

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1420

4127

2.57

209.89

2.7

2.0

498.64

594.99

ug/l

0.62

1344

3851

(3029937) Albumin [Presence] in Urine by Test strip

7180

36523

1.58

205.10

5.0

3.9

0.01

0.00

estimate

1.25

2424

11849

(3023199) Leukocytes [#/volume] in Pleural fluid

631

1125

4.12

204.10

1.6

1.4

2530.36

3357.80

e6/l

0.49

469

835

(3028271) Lactate [Moles/volume] in Capillary blood

790

1673

3.48

201.61

2.0

1.7

1.71

1.75

mmol/l

0.40

772

1634

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

194

19.58

200.00

7.4

4.1

67.95

60.73

0.74

165

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1266

3601

2.62

195.06

1.9

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2021

7094

2.15

194.87

1.8

1.6

—

(3015736) pH of Urine

9879

54407

1.51

194.50

4.2

3.2

5.84

5.82

0.15

341

3663

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2743

10825

1.93

192.07

2.9

2.5

56.60

67.90

ml/min/173m2

39.29

1217

4004

(3047181) Lactate [Moles/volume] in Blood

1302

3807

2.55

189.71

9.3

5.0

1.29

1.28

mmol/l

0.16

1168

3327

(3028308) Erythrocytes [#/volume] in Pleural fluid

581

1028

4.15

189.71

1.5

1.4

45904.21

56765.29

e6/l

0.50

358

639

(40760888) Immunoglobulin light chains.free panel - Serum

1075

2861

2.79

187.93

3.4

3.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1055

2782

2.81

187.58

3.6

2.7

24.73

24.58

mmol/l

0.44

1031

2726

(3012441) Differential panel - Pleural fluid

559

969

4.23

187.30

1.6

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1032

2691

2.84

187.26

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1007

2603

2.87

185.60

1.6

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8808

47713

1.51

184.95

3.4

3.6

2.34

2.36

mmol/l

22.99

7601

41570

(3000012) Reticulocyte production index

771

1704

3.34

184.34

2.4

2.2

—

(40761511) CBC panel - Blood by Automated count

22370

147916

1.82

182.90

23.8

11.5

—

(3021901) Oxygen saturation in Capillary blood

831

1937

3.17

182.64

3.3

2.4

—

(3039000) Anion gap in Blood

1012

2685

2.79

177.80

10.3

5.9

10.89

11.13

mmol/l

1.34

934

2403

(3018572) Chloride [Moles/volume] in Blood

1012

2686

2.79

177.68

10.4

5.9

105.36

105.25

mmol/l

0.26

934

2404

(3028626) Oxygen [Partial pressure] in Capillary blood

1008

2671

2.79

177.51

4.5

3.3

8.16

8.47

kpa

5.94

986

2607

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1595

5289

2.25

176.11

1.5

1.6

14.55

16.49

u/ml

0.17

168

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5958

29875

1.57

175.88

1.8

1.7

33609548.05

32852536.80

pmol/l

0.03

4835

24382

(3012516) Albumin [Mass/volume] in Urine

8135

43838

1.50

171.89

3.6

3.2

521.84

386.37

mg/l

1.56

5421

27118

(3022806) Fractional oxyhemoglobin in Capillary blood

641

1313

3.59

171.59

1.9

1.7

89.43

89.82

0.74

631

1296

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2738

11219

1.85

169.71

5.5

3.4

1.22

1.23

mmol/l

23.95

2415

9638

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

491

833

4.32

168.93

1.4

1.3

268.85

684.70

u/l

6.89

465

788

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20520

133263

1.60

167.90

6.9

5.7

40.54

39.80

mmol/mol

20.58

18769

121915

(3020682) Albumin/Creatinine [Ratio] in Urine

8476

46232

1.49

167.74

4.2

3.7

15.15

6.00

mg/mmol

33.62

5480

28571

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

904

2331

2.86

167.16

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1349

4253

2.36

167.02

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3985

18346

1.67

164.83

10.4

5.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9346

52280

1.46

160.87

5.0

3.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20724

135460

1.59

156.64

4.8

3.9

1.26

1.31

mmol/l

22.58

18814

122103

(3045788) Cell count panel - Pleural fluid

481

853

4.13

156.54

1.6

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

8290

45765

1.46

149.92

3.5

3.1

6.92

7.80

mmol/l

65.94

6866

38337

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2970

12919

1.75

149.80

2.3

0.20

0.22

g/l

38.95

2731

12071

(3036782) Glucose [Moles/volume] in Pleural fluid

470

849

4.05

149.37

1.4

1.3

6.73

5.60

mmol/l

12.23

442

764

(40768806) Pleura Pathology biopsy report

523

1037

3.69

146.57

1.6

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

640

1460

3.22

145.42

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

768

1978

2.86

142.12

1.6

1.7

—

(40761535) Cells panel - Urine sediment

2626

11219

1.77

140.35

4.1

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1898

7319

1.94

140.11

2.1

1.9

1.28

1.35

g/l

0.51

1730

6616

(3005719) IgG [Mass/volume] in Serum or Plasma

2312

9553

1.82

137.94

3.0

2.8

10.81

10.54

g/l

1.61

2121

8713

(3022313) Gas panel - Capillary blood

1601

5842

2.04

137.92

5.2

3.4

—

(40761536) Microorganisms panel - Urine sediment

2606

11164

1.76

137.83

4.8

3.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

763

2000

2.81

136.74

1.5

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22760

153391

1.74

135.89

28.7

14.3

89.10

76.40

umol/l

246.09

22754

153343

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

684

1697

2.96

135.16

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1232

4135

2.21

131.28

1.7

1.6

246.78

255.36

titre

0.04

195

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1069

3411

2.32

128.23

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

394

700

4.11

127.92

1.4

1.2

11.77

16.13

u/l

1.97

355

672

(3037756) Immunofixation for Serum or Plasma

886

2598

2.51

127.64

1.6

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21331

141900

1.55

126.98

5.4

4.4

4.31

4.72

mmol/l

307.65

19631

129898

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21176

140643

1.54

126.96

5.4

4.4

1.42

1.47

mmol/l

69.05

19374

127955

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

905

2690

2.48

126.74

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21139

140359

1.54

126.67

5.5

4.6

6.06

5.98

mmol/l

17.37

19014

126851

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

616

1497

3.02

126.08

1.5

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

875

2573

2.51

125.30

2.9

2.7

34.04

34.83

umol/l

0.40

807

2315

(40758558) Short blood count panel - Blood

6429

34907

1.44

121.07

7.2

—

(3037522) Nuclear Ab [Titer] in Serum

3506

16767

1.59

120.93

1.4

1.3

599.20

533.43

titre

1.08

835

3481

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1393

5065

2.04

120.75

2.4

2.3

7.25

7.40

g/l

2.45

1247

4507

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1391

5061

2.04

120.36

2.4

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1387

5049

2.04

119.83

2.4

2.3

3.67

3.72

g/l

0.57

1242

4497

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9703

56683

1.38

119.68

2.5

2.2

78.76

78.67

nmol/l

0.10

8554

50201

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1701

6687

1.90

117.87

3.3

4.28

4.50

pmol/l

13.33

1518

5896

(3004451) EKG impression Narrative

279

398

5.10

117.16

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21652

145054

1.55

116.96

6.1

4.9

2.46

2.80

mmol/l

307.65

19895

132133

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22664

153512

1.65

116.41

14.0

10.0

25.85

26.59

u/l

3.80

21820

147084

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1308

4716

2.06

115.88

2.4

2.3

10.25

10.24

g/l

0.01

1157

4130

(3051593) INR in Capillary blood by Coagulation assay

283

416

4.95

115.04

13.6

3.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

612

1591

2.82

111.24

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

520

1232

3.09

111.04

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

873

2714

2.37

110.85

2.7

1.9

124.40

132.03

g/l

12.10

664

1891

(3022493) Free Hemoglobin [Mass/volume] in Plasma

281

426

4.80

110.39

7.8

1.2

741.27

2020.42

mg/l

0.56

225

287

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2501

11231

1.67

110.19

2.2

2.4

377.13

372.70

nmol/l

0.40

2302

10314

(3019150) Specific gravity of Urine by Refractometry

5518

29582

1.44

109.27

5.2

3.9

1.02

kg/l

1.20

819

4640

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3201

15347

1.58

108.21

2.9

10.29

9.33

umol/l

1.22

2779

13387

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1036

3522

2.17

106.64

1.8

1.5

1.13

1.19

g/l

9.51

982

3332

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1290

4772

2.00

106.38

2.4

2.3

3.05

2.88

g/l

7.20

1144

4216

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4645

24280

1.47

104.33

3.2

2.7

1.21

1.12

e6/l

0.53

2830

13724

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1004

3404

2.17

104.01

1.8

1.5

0.23

0.24

g/l

3.94

948

3200

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1315

4939

1.97

103.85

1.9

1.8

38.48

40.09

u/l

1.77

1112

4425

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

670

1900

2.59

103.17

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5913

32394

1.41

102.85

4.5

3.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

396

830

3.48

102.45

1.6

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1363

5212

1.94

102.17

5.7

3.5

24.91

24.76

mmol/l

0.97

1266

4805

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1000

3410

2.16

102.10

4.7

4.0

1.87

1.38

mg/l

39.15

913

3126

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1183

4327

2.02

100.54

2.6

2.5

0.96

1.01

g/l

0.15

998

3688

(3017181) Myelocytes/100 leukocytes in Blood

2524

11620

1.63

100.41

4.4

4.0

0.95

0.96

0.13

979

3897

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4918

26203

1.44

99.23

2.9

3.3

2.46

mmol/l

0.43

4272

22974

(3021440) Promyelocytes/100 leukocytes in Blood

2407

11046

1.63

96.78

4.4

4.1

0.13

0.11

0.62

864

3348

(3035880) pH of Pleural fluid

285

489

4.24

96.75

1.4

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

487

1213

2.93

95.52

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

487

1213

2.93

95.52

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

791

2518

2.31

95.12

7.0

5.3

641.17

1390.49

iu/ml

0.58

157

373

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

650

1891

2.52

95.02

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

650

1891

2.52

95.02

1.6

1.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2310

10544

1.64

94.78

4.3

3.9

0.63

0.70

0.83

853

3337

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1338

5236

1.89

93.44

2.0

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

752

2360

2.34

93.39

1.3

1.2

77.33

123.10

titre

0.81

(40768797) Stomach Pathology biopsy report

3730

19074

1.48

92.31

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

2285

10473

1.63

92.09

4.4

4.1

0.30

0.37

0.18

743

2812

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1245

4788

1.92

91.57

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20380

136397

1.41

90.82

22.2

11.6

73.31

80.32

ml/min/173m2

307.65

17778

110413

(3042631) Mycobacterium sp identified in Specimen

602

1732

2.54

90.01

2.4

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

869

2955

2.16

89.23

2.0

1.9

12.37

10.78

mg/l

2.62

799

2733

(3020876) Protein [Mass/time] in 24 hour Urine

491

1283

2.80

88.40

2.8

2.5

1.32

1.14

g/24h

0.70

272

593

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1031

3760

2.02

88.17

2.5

2.3

0.03

g/l

0.16

930

3441

(3011648) Oxygen content in Venous blood

360

787

3.33

87.45

2.9

3.0

10.76

10.81

0.06

360

787

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

346

737

3.42

87.43

1.6

1.4

14.30

11.64

u/l

7.42

332

712

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

769

2508

2.25

87.37

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

769

2508

2.25

87.37

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

972

3481

2.05

87.30

2.5

2.3

0.00

g/l

0.16

872

3176

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1070

3978

1.98

86.72

2.4

2.2

36.68

38.45

g/l

17.16

927

3409

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

633

1901

2.44

86.55

3.2

2.9

2248.69

8561.66

u/ml

0.68

128

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

956

3437

2.05

84.95

2.5

2.3

0.00

g/l

-0.00

869

3167

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

941

3400

2.04

82.48

1.6

1.4

18.39

13.11

iu/ml

0.53

(3017143) Hepatitis C virus Ab [Presence] in Serum

2606

12673

1.54

81.08

1.8

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

257

469

3.98

80.70

40.9

32.8

7.29

7.25

ug/l

0.12

241

421

(21494755) Public health laboratory ask at order entry panel

792

11154

0.50

80.45

1.3

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

462

1232

2.74

80.12

1.9

2.1

—

(3003694) ABO and Rh group [Type] in Blood

6537

37635

1.34

79.82

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

18475

122534

1.33

78.66

28.0

14.8

15.42

15.07

7.70

18203

120060

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

202

315

4.65

76.96

1.6

1.3

65.75

58.98

1.56

164

273

(3041096) Erythrocytes [Presence] in Urine by Automated

6268

36068

1.34

76.07

4.2

3.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9319

56715

1.29

75.23

5.0

2.68

3.49

ug/l

4.03

8157

51147

(3009542) Hematocrit [Volume Fraction] of Blood

23110

159504

1.55

74.53

36.4

18.3

38.85

40.51

77.33

21421

148211

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13994

89833

1.28

73.20

3.6

3.0

61.05

50.16

u/l

27.28

12817

82711

(3007461) Platelets [#/volume] in Blood

23109

159599

1.54

72.70

35.8

18.3

231.82

250.55

e9/l

307.65

22639

154185

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

609

1951

2.28

72.11

1.2

1.3

41.13

34.04

u/l

0.68

538

1658

(3007164) IgA [Mass/volume] in Serum or Plasma

4404

24174

1.38

71.75

1.6

1.4

2.64

2.48

g/l

4.86

2769

13830

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

283

602

3.42

71.72

2.1

2.5

89.49

99.14

4.38

274

570

(3035941) MCH [Entitic mass]

23110

159680

1.54

71.43

35.6

18.2

30.38

30.39

0.10

22821

156741

(3000093) Morphology [Interpretation] in Blood Narrative

433

1186

2.66

71.39

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

23112

159717

1.54

71.08

35.8

18.3

6.92

6.66

e9/l

33.16

22567

153684

(3024731) MCV [Entitic volume]

23110

159705

1.54

70.99

35.7

18.2

91.70

91.12

67.05

22820

156754

(3026361) Erythrocytes [#/volume] in Blood

23111

159715

1.54

70.97

35.8

18.2

4.32

4.52

e12/l

307.65

22569

153675

(3000963) Hemoglobin [Mass/volume] in Blood

23113

159750

1.54

70.65

36.1

18.3

130.00

136.57

g/l

307.65

22830

156799

(3042733) HLA Ab [Presence] in Serum

198

328

4.38

70.29

5.3

4.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

17.46

69.07

14.9

8.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

685

2378

2.11

66.66

1.8

1.4

—

(3000494) Fungus identified in Specimen by Culture

3138

16449

1.43

66.22

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

631

2135

2.16

65.53

1.8

1.4

128.25

108.57

u/ml

1.56

175

472

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1621

7414

1.62

64.99

2.6

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

678

2375

2.09

64.46

1.7

1.4

14.43

18.65

u/ml

0.58

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2807

14492

1.45

64.15

1.8

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4107

22680

1.37

63.52

3.5

2.8

2.35

2.33

e6/l

0.05

2301

12203

(3042111) Morphology [Interpretation] in Bone marrow Narrative

634

2182

2.12

63.08

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

170

272

4.53

62.94

1.6

1.3

1.80

3.00

1.36

141

240

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

298

712

3.04

62.87

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

253

550

3.34

62.10

2.2

26.83

45.27

umol/l

0.58

(3003181) Sodium [Moles/volume] in Urine

645

2257

2.09

61.49

1.4

61.12

65.15

mmol/l

1.70

531

1794

(3025941) Bacteria identified in Stool by Culture

1502

6864

1.62

60.31

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

920

3685

1.83

59.38

1.9

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

234

498

3.41

59.34

27.4

28.0

106.22

118.89

ug/l

2.20

181

436

(3037121) Protein [Mass/volume] in Urine

1100

4652

1.74

59.17

3.2

3.4

0.36

0.29

g/l

1.72

523

2034

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4856

27787

1.32

58.65

1.3

2.08

1.81

u/ml

0.53

1275

7059

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

268

627

3.11

58.58

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

268

628

3.10

58.43

1.6

1.5

—

(4200892) Spirometry reversibility

2047

10104

1.50

58.40

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

164

272

4.37

58.21

1.5

1.2

2.96

4.48

mmol/l

4.79

152

255

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

386

1110

2.53

57.85

3.5

2.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

55.81

2.6

0.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

624

2248

2.03

55.06

5.8

2.5

—

(3019225) pH of Specimen

2760

14583

1.41

54.95

5.5

3.8

—

(3023419) Bacteria identified in Sputum by Culture

548

1881

2.13

54.91

2.4

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3123

16914

1.38

53.62

1.9

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

16.56

53.09

1.2

1.1

91.68

123.21

ug/l

0.32

(3040151) Glucose [Moles/volume] in Capillary blood

425

1335

2.32

52.71

6.1

6.6

7.05

7.60

mmol/l

2.14

368

1094

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

952

11288

0.59

52.29

1.9

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1093

4773

1.68

52.27

1.2

2.02

0.76

u/ml

1.45

105

427

(3034770) Mitochondria Ab [Titer] in Serum

838

3395

1.81

52.10

1.2

1010.63

972.96

titre

0.05

108

(3019977) pH of Arterial blood

238

562

3.07

51.29

2.7

2.2

7.43

7.42

1.32

196

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

873

3601

1.78

51.12

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

921

3864

1.75

50.88

4.2

3.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

554

1978

2.04

50.10

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

591

2161

2.00

50.07

1.5

1.3

295.44

271.29

u/ml

1.12

405

1318

(3014891) Appearance of Pleural fluid

6.92

49.84

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

622

2322

1.96

49.69

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

219

502

3.17

49.57

1.2

1.1

4.80

3.12

iu/ml

1.32

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

136

221

4.46

49.54

1.6

1.3

21.23

22.40

0.17

115

194

(3000919) Neutrophils/100 leukocytes in Pleural fluid

143

243

4.26

49.35

1.5

1.3

21.97

23.58

0.23

127

227

(3007566) Smooth muscle Ab [Titer] in Serum

832

3436

1.77

48.51

1.2

126.75

138.17

titre

0.14

295

(3016750) Collection duration of Urine

286

777

2.67

48.04

2.4

2.1

499.48

497.46

min

0.12

219

582

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

601

2.91

47.37

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

601

2.91

47.37

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

108

6.16

47.09

12.5

7.6

5.24

5.44

mmol/l

0.19

108

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

500

1762

2.07

46.84

1.3

1.2

5.43

3.91

u/ml

0.61

209

607

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

124

5.72

46.74

1.6

1.3

9.50

11.58

0.32

(4094501) Cardiovascular stress test using bicycle ergometer

867

3671

1.73

46.36

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

275

749

2.67

45.99

2.1

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

480

1689

2.07

45.16

1.3

1.2

4.88

3.68

u/ml

1.16

233

746

(3044927) Protein electrophoresis panel - Urine

393

1280

2.23

44.87

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

717

2910

1.80

44.31

4.3

2.6

1.54

1.60

mmol/l

0.63

705

2857

(3012565) Volume of 24 hour Urine

236

607

2.82

43.94

2.4

2.2

1729.17

2063.57

5.09

206

538

(3049717) Cytology report of Urine Cyto stain

1183

5527

1.57

43.03

2.7

2.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

156

316

3.58

42.68

1.6

2.4

213.93

162.21

4.56

151

300

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

337

1054

2.32

42.30

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

337

1054

2.32

42.30

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

337

1054

2.32

42.30

1.5

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

802

3416

1.72

41.98

2.5

2.3

134.27

91.80

ug/min

1.81

485

1995

(3042010) Triglyceride [Moles/volume] in Pleural fluid

129

5.27

41.36

1.4

1.2

0.54

2.32

mmol/l

2.02

(3038515) Glucose [Moles/volume] in Venous blood

681

2791

1.78

40.75

4.4

2.6

7.44

7.63

mmol/l

0.93

671

2749

(3041918) Cholesterol [Moles/volume] in Pleural fluid

107

169

4.58

40.38

1.3

1.1

1.16

2.13

mmol/l

12.55

106

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7294

45474

1.22

40.22

4.5

4.2

22.46

21.68

3.96

3671

22647

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

138

271

3.69

39.49

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

11849

77458

1.20

39.27

2.6

2.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

184

438

3.05

39.25

1.6

2.3

172.63

146.86

2.91

172

414

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.12

39.22

1.3

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3828

22289

1.28

38.54

1.3

35.13

41.04

iu/ml

1.11

1199

7131

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

256

740

2.51

38.13

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

340

1121

2.20

37.78

2.6

2.2

697.69

675.95

0.41

253

749

(3011544) Albumin [Mass/volume] in Pleural fluid

6.34

37.35

1.2

1.1

16.05

21.13

g/l

4.76

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.85

37.11

1.4

1.2

47.71

395.97

u/l

0.67

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

140

291

3.48

36.96

1.4

1.2

249.11

482.59

ug/l

0.51

174

(44786800) Granulocytes/100 leukocytes in Body fluid

119

5.17

36.68

1.5

1.3

17.88

28.82

1.95

(3017569) Oxygen content in Arterial blood

191

485

2.85

36.49

2.3

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

462

1739

1.93

36.13

1.4

1.3

0.27

0.29

nmol/l

0.09

133

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

361

1243

2.11

36.03

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

593

7218

0.58

35.74

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

427

1570

1.98

35.72

3.1

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

460

1739

1.92

35.52

1.4

1.3

4.74

1.50

nmol/l

0.56

444

1682

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

339

1149

2.14

35.22

2.4

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

242

708

2.48

35.20

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

558

2257

1.80

34.93

3.6

3.4

1.38

1.59

0.79

501

1969

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

384

1370

2.04

34.92

1.2

64.96

66.97

u/l

0.10

348

1216

(3017704) Immunofixation for Urine

231

664

2.52

34.85

1.5

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

806

3616

1.63

34.67

1.2

—

(3051651) Icteric interference index of Serum or Plasma

241

709

2.47

34.66

5.5

3.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

160

379

3.06

34.48

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

380

1358

2.03

34.41

1.6

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

7.79

34.35

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

810

3647

1.62

34.35

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

811

3660

1.62

34.07

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

256

781

2.38

34.06

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

139

304

3.31

34.04

1.6

1.3

15.57

11.45

g/l

5.37

113

226

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

259

797

2.36

33.82

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

677

2924

1.69

33.71

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

179

461

2.81

33.38

1.8

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

6.49

33.37

1.3

1.1

6.23

9.46

mg/l

1.33

(40762365) Oxygen content in Arterial blood by calculation

103

186

4.01

33.07

2.6

3.7

15.29

14.83

ml/dl

0.71

178

(3047189) Immunofixation for 24 hour Urine

200

551

2.63

32.87

1.7

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

744

3321

1.63

32.66

1.8

1.6

16953.47

12456.11

e6/l

1.27

560

2384

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

329

1136

2.10

32.65

2.3

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

153

365

3.04

32.61

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

284

925

2.23

32.57

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

440

1688

1.90

32.56

1.3

1.5

77.77

65.82

mu/l

0.40

390

1507

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1445

7443

1.42

32.52

3.3

2.6

0.25

0.27

e6/l

0.25

1411

7265

(3024471) HLA-A [Type]

157

382

2.98

32.37

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2303

12801

1.33

32.34

2.7

2.5

43.88

51.59

u/l

0.42

1973

10965

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

320

1098

2.12

32.28

1.2

—

(3024932) HLA-DR beta [Type]

154

374

2.98

31.86

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3561

20994

1.26

31.75

1.3

1.2

13.93

14.32

u/ml

0.07

1272

7790

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

419

1600

1.90

31.46

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

733

3297

1.62

31.22

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

694

3104

1.63

30.25

1.3

1.2

3.37

3.48

u/ml

0.04

309

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

821

3825

1.57

30.20

1.6

1.5

26.69

5.96

iu/ml

0.61

182

833

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

699

3146

1.62

29.72

1.3

10.37

5.72

u/ml

1.11

141

504

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

603

2617

1.68

29.53

1.3

1.2

3.83

3.73

u/ml

0.02

189

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

187

528

2.57

29.34

2.5

2.3

—

(3000492) Spirometry study

2242

12591

1.31

29.13

1.6

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1558

8284

1.38

29.11

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

432

1713

1.83

28.91

1.6

1.5

64.55

56.11

4.33

290

1057

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

407

1591

1.86

28.50

1.2

1.4

281.66

368.53

pmol/l

0.70

344

1361

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

153

4.06

28.21

4.7

5.7

55.74

41.00

ug/min

1.07

120

(3051611) Lipemic interference index of Serum or Plasma

362

1379

1.91

27.44

4.7

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

176

499

2.55

27.43

2.3

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

594

2623

1.65

27.26

1.3

1.2

9.70

16.84

u/ml

0.40

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

733

3413

1.57

27.05

1.3

1.2

31.64

42.67

u/ml

0.62

199

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

501

2120

1.72

26.96

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

437

1778

1.79

26.93

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

333

1242

1.95

26.87

1.4

7.30

6.65

g/l

1.64

228

852

(3024139) IgG subclass 3 [Mass/volume] in Serum

332

1242

1.94

26.56

1.4

0.44

0.41

g/l

0.72

226

851

(3016038) Potassium [Moles/volume] in Urine

250

842

2.15

26.53

1.1

1.2

36.45

34.37

mmol/l

0.63

217

713

(3024980) IgG subclass 4 [Mass/volume] in Serum

482

2027

1.73

26.52

1.4

1.6

0.77

0.85

g/l

0.73

339

1522

(3028192) IgG subclass 2 [Mass/volume] in Serum

332

1243

1.94

26.50

1.4

2.84

2.95

g/l

0.44

225

856

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

633

2864

1.61

26.38

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

336

1267

1.93

26.27

1.4

1.3

170349.78

85836.54

e6/l

1.13

240

860

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

335

1264

1.92

26.15

1.6

1.5

25.01

32.36

3.49

218

753

(3022145) Colonoscopy Study observation

2779

16270

1.26

25.89

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

167

3.77

25.85

1.3

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.98

25.84

1.2

1.1

15.23

25.80

u/l

3.37

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

152

416

2.65

25.43

2.4

1.8

27153.70

6405.51

e6/l

1.07

222

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

604

2.34

25.24

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

604

2.34

25.24

1.4

1.5

—

(4062490) Immunoglobulin typing, IgG

325

1234

1.91

24.93

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6108

38787

1.18

24.88

1.7

1.6

1.33

1.37

mmol/l

3.11

4887

32355

(3005322) IgE [Units/volume] in Serum or Plasma

1391

7446

1.37

24.87

1.3

229.06

270.97

u/ml

0.88

1269

6870

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.69

24.63

1.6

1.3

77.89

70.73

0.91

(3021788) Differential panel - Synovial fluid

560

2506

1.63

24.43

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

240

824

2.11

24.31

1.6

1.5

8.78

6.86

u/l

0.73

193

675

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

183

566

2.34

23.80

3.3

4.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

7.86

23.31

1.1

1.2

0.06

0.08

g/l

0.83

(21494434) Karyotype in Bone marrow

312

1199

1.89

23.12

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

181

3.48

23.12

4.8

6.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

163

485

2.43

23.08

2.6

1.9

5591.88

4507.06

e6/l

0.08

120

325

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

417

1755

1.73

22.95

1.1

1.58

1.51

g/l

2.31

375

1581

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.23

22.91

1.3

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

411

1724

1.73

22.89

1.2

1.1

107.51

120.08

10.19

380

1550

(3033799) Differential panel - Peritoneal fluid

146

414

2.55

22.84

2.4

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

319

2.79

22.82

2.9

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

123

319

2.79

22.82

2.9

2.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

374

1540

1.76

22.22

1.2

70.31

56.32

u/ml

0.49

(3001019) Free T4 and TSH panel - Serum or Plasma

459

5280

0.62

21.93

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

376

1559

1.75

21.83

4.0

3.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

828

4143

1.46

21.77

1.4

259.24

269.31

ug/g

0.76

496

2437

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

272

1020

1.93

21.72

1.8

2.0

4.30

3.57

mg/l

1.83

263

968

(3034426) Prothrombin time (PT)

132

368

2.60

21.39

1.3

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1068

5612

1.39

21.38

1.1

123.70

228.81

titre

1.75

147

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.37

20.90

2.4

2.1

62.63

54.45

0.71

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2717

16237

1.23

20.79

3.5

4.4

26.31

27.49

ug/l

0.07

2206

13417

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

768

2.06

20.73

1.3

1.2

107.91

82.25

u/l

2.83

191

664

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

212

744

2.06

20.38

1.3

1.2

28.94

22.07

u/l

1.12

182

622

(3014271) Vancomycin [Susceptibility]

195

664

2.13

20.27

3.2

2.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

131

3.75

20.20

1.1

1.3

6.45

401826.71

nmol/l

1.29

110

(3002256) Pathology report gross observation

3138

19082

1.21

20.19

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

+∞

20.12

1.4

0.0

0.58

—

umol/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

404

1754

1.67

19.91

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

185

626

2.14

19.55

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

116

318

2.64

19.48

1.1

74.57

88.91

4.08

140

(3011412) CD3 cells [#/volume] in Blood

314

1278

1.78

19.47

2.3

2.6

1.04

1.24

e9/l

1.47

285

1159

(4034850) Laboratory test

869

4482

1.41

19.41

15.9

8.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

394

1713

1.67

19.33

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

118

328

2.60

19.29

1.2

93.45

108.01

2.61

106

302

(3002331) Protein [Mass/volume] in Peritoneal fluid

107

283

2.73

19.23

1.6

1.4

28.08

28.97

g/l

0.06

213

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

170

560

2.20

19.21

2.5

1.8

1447.18

1402.49

u/ml

0.05

165

552

(3008295) Osmolality of Serum or Plasma

323

1333

1.76

19.12

1.3

1.4

276.45

280.08

mosm/kgh2o

1.69

267

1031

(3025468) Yersinia sp identified in Specimen by Organism specific culture

388

1691

1.67

18.88

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

407

1799

1.64

18.75

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

185

3.17

18.75

2.6

3.1

54.40

49.84

mg/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

666

3292

1.47

18.69

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

156

503

2.24

18.57

3.1

2.2

9.62

10.05

mmol/l

0.81

151

494

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

391

1716

1.65

18.53

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

387

1695

1.66

18.49

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

387

1698

1.65

18.36

1.4

—

(3045142) Bone marrow Pathology biopsy report

368

1595

1.67

18.30

1.3

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

144

452

2.31

18.25

2.3

1.7

44356.22

29158.70

u/ml

0.13

(3044007) Cell count panel - Peritoneal fluid

130

391

2.41

18.11

2.5

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

128

383

2.42

18.03

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

8.09

18.03

1.4

1.0

3179.23

207.18

ng/l

3.82

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

126

3.61

17.82

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

237

912

1.88

17.63

2.3

2.2

—

(40768443) Skin Pathology biopsy report

1168

6417

1.33

17.59

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

314

2.56

17.57

1.1

72.42

91.11

4.50

141

(1175426) CD3 cells/100 lymphocytes in Blood

253

998

1.84

17.43

2.2

72.62

71.50

0.46

239

954

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.88

17.32

3.4

2.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

251

991

1.84

17.25

1.2

150.41

173.89

titre

0.23

185

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.33

17.21

2.1

11.13

29.58

2.27

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

301

1257

1.74

17.16

3.7

3.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

248

978

1.84

17.12

2.1

2.2

14.93

15.92

0.69

240

949

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

250

990

1.83

17.03

1.2

213.64

103.64

titre

0.44

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

175

614

2.06

16.93

1.1

—

(3044941) Cell count panel - Synovial fluid

450

2092

1.56

16.89

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

142

461

2.23

16.69

1.5

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

203

2.92

16.66

1.2

1.1

78.30

85.06

0.60

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

568

2785

1.48

16.65

1.7

1.8

21.14

14.14

iu/l

0.16

180

981

(3017354) Segmented neutrophils/100 leukocytes in Blood

330

1426

1.68

16.64

3.7

3.5

59.79

56.08

2.22

290

1163

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

200

2.93

16.53

1.1

76.21

72.00

0.34

(3017732) Neutrophils [#/volume] in Blood

1641

9510

1.26

16.42

3.0

2.9

6.33

4.75

e9/l

2.87

1227

7450

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

4.01

16.32

1.1

9.89

24.81

iu/ml

0.80

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

511

2475

1.50

15.92

1.2

47.02

40.52

u/ml

0.45

223

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

147

496

2.14

15.76

2.5

3.0

—

(3010503) CD19 cells [#/volume] in Blood

211

812

1.88

15.76

2.4

2.7

0.27

0.43

e9/l

0.44

203

791

(3014148) Varicella zoster virus Ab [Titer] in Serum

312

1351

1.67

15.65

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

752

3945

1.39

15.29

4.4

3.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.16

15.26

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

183

680

1.95

15.18

1.1

38.79

20.85

u/l

1.71

167

610

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

332

1476

1.63

15.06

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

119

375

2.30

15.04

1.3

1.5

15.50

14.62

pmol/l

1.10

316

(3034891) Synovial lining cells/100 cells in Synovial fluid

176

650

1.96

14.87

1.6

1.5

2.43

4.30

1.20

125

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

182

682

1.93

14.75

1.1

105.22

78.64

u/l

2.39

165

614

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

310

1366

1.64

14.58

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

296

1291

1.66

14.49

1.2

1.1

89.65

97.82

5.37

282

1204

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

216

2.71

14.46

1.5

1.3

103.49

111.32

0.95

205

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.94

14.32

6.3

5.9

414.24

473.08

umol/l

0.50

(3000330) Specific gravity of Urine by Test strip

1276

7295

1.28

14.29

4.1

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

467

2272

1.49

14.29

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

370

2.27

14.29

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

182

690

1.91

14.27

1.2

1.1

1.08

1.07

ratio

0.62

247

(3016228) CD19 cells/100 cells in Blood

149

527

2.05

14.20

2.2

2.0

8.43

8.58

0.04

143

512

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

145

509

2.06

14.10

1.1

28.18

6.30

u/ml

0.58

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3025

18902

1.18

14.03

5.2

4.6

33.40

32.14

7.89

2161

12203

(3004616) Nuclear Ab [Presence] in Serum

340

1551

1.59

13.93

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1014

5649

1.31

13.87

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

144

512

2.03

13.56

2.1

2.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

120

399

2.17

13.42

1.4

1.3

59.13

51.67

1.22

345

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

238

1007

1.71

13.09

1.6

26.30

23.54

u/ml

0.34

216

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

433

2.10

12.99

2.9

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

121

411

2.13

12.86

2.3

2.0

—

(40768804) Tissue Pathology biopsy report

8676

58403

1.11

12.55

2.2

2.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

121

417

2.10

12.41

1.2

0.57

1.05

g/l

0.38

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

11.55

12.36

7.3

9.1

43.29

52.40

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

301

1375

1.59

12.33

1.2

1.1

1.70

2.19

iu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

162

624

1.88

12.19

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1070

9651

0.79

11.98

1.3

—

(3012898) Urea [Moles/volume] in Urine

102

3.33

11.93

1.2

1.5

154.44

188.98

mmol/l

0.89

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.33

11.91

6.3

3.3

12.67

12.89

0.02

(3010838) Calcium [Moles/time] in 24 hour Urine

478

2424

1.43

11.90

1.8

1.9

4.37

5.23

mmol/24h

6.43

412

2109

(40757373) Influenza virus identified in Isolate

222

2.51

11.89

1.4

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

121

3.10

11.84

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

377

1835

1.49

11.61

2.6

1.9

21.89

28.98

mg/l

1.78

484

(3016650) Hepatitis A virus Ab [Presence] in Serum

405

2002

1.47

11.55

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

131

2.98

11.49

2.0

—

(3045414) Leukocytes [Presence] in Urine

1063

6119

1.26

11.30

2.0

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

161

2.74

11.20

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

122

440

2.00

11.15

2.6

1.4

23.29

551.62

ug/l

1.42

116

414

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

388

1919

1.47

11.06

1.7

2.0

23.44

27.00

ug/l

0.46

372

1889

(3029634) Reagin Ab [Titer] in Serum by VDRL

343

1655

1.50

11.05

2.0

2.2

3.86

6.92

titre

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

166

667

1.80

10.99

3.4

3.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

170

2.63

10.62

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

168

689

1.76

10.42

1.5

1.9

—

(3003129) Base excess in Capillary blood by calculation

325

2.13

10.39

2.0

1.5

1.69

0.29

mmol/l

2.43

308

(3048689) Calprotectin [Mass/mass] in Stool

2453

15425

1.16

10.38

2.1

2.3

154.88

140.66

ug/g

1.01

1918

12096

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

310

1491

1.51

10.18

1.1

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

167

690

1.75

10.11

1.5

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

529

1.86

10.03

1.2

143.72

166.25

mmol/24h

2.70

136

529

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

281

1332

1.53

9.89

1.2

—

(3048879) Bone marrow aspiration report

109

395

1.99

9.89

1.4

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

128

2.82

9.75

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

100

353

2.05

9.75

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

376

1898

1.44

9.69

1.4

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

109

2.98

9.66

1.1

—

(3036603) Volume of Urine

199

876

1.64

9.59

1.6

1.5

1863.03

1878.32

0.09

192

842

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

197

865

1.65

9.59

1.4

14.64

12.26

umol/l

4.09

192

816

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

400

2049

1.41

9.52

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

248

1154

1.56

9.51

2.2

2.3

37.97

37.06

0.37

242

1141

(3036670) Protein [Mass/volume] in Synovial fluid

113

421

1.94

9.50

1.2

1.3

39.07

39.71

g/l

0.15

226

(3027008) Opiates [Presence] in Urine

313

3263

0.69

9.49

2.4

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1507

9167

1.20

9.49

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

212

952

1.61

9.45

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

311

3242

0.69

9.43

2.5

2.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

207

925

1.62

9.41

2.2

2.7

433.90

575.72

e6/l

2.15

170

788

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

130

510

1.84

9.37

1.5

1.7

4.53

9.67

nmol/l

0.50

113

421

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

249

2.23

9.36

2.5

7.84

7.54

mmol/l

0.13

147

(3028300) Cannabinoids [Presence] in Urine

315

3270

0.69

9.34

2.6

2.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

204

2.37

9.33

4.1

3.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

130

511

1.84

9.32

1.1

90.68

98.22

1.51

109

409

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

9.02

9.28

8.3

8.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

599

3289

1.32

9.23

3.0

3.5

1569.99

799.35

u/ml

0.33

543

2994

(3006270) Folate [Moles/volume] in Blood

240

1117

1.56

9.21

1.2

1.1

322.48

351.24

nmol/l

1.39

203

923

(3052592) Norovirus Ag [Presence] in Stool

237

2.26

9.20

1.3

—

(3027944) Amphetamines [Presence] in Urine

307

3192

0.69

9.19

2.2

1.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

222

1016

1.58

9.16

1.3

1.2

19.56

40.49

u/ml

1.57

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

194

859

1.63

9.16

1.3

216.47

437.69

titre

0.69

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

189

832

1.64

9.13

1.3

121.18

61.59

titre

0.37

(3005570) Glucose [Moles/volume] in Urine

281

1358

1.50

9.08

2.1

1.8

—

6.84

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

221

1013

1.58

9.07

1.3

1.2

67.85

84.76

u/ml

0.35

(3003327) Ova and parasites identified in Stool by Light microscopy

737

4174

1.28

9.03

1.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

212

965

1.59

8.96

1.3

1.2

12.75

5.41

u/ml

0.38

(3038026) Centromere Ab [Units/volume] in Serum

226

1045

1.57

8.94

1.3

1.2

35.34

59.72

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

826

4754

1.26

8.88

1.7

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

327

2.03

8.85

1.1

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

237

2.23

8.82

1.2

1.1

3.40

9.77

pmol/l

0.40

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2138

17590

0.87

8.79

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

331

3367

0.71

8.77

1.6

—

(3028433) Virus identified in Specimen by Culture

118

459

1.86

8.77

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

249

2.18

8.60

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.36

8.57

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.74

8.48

1.1

—

(3003338) MCHC [Mass/volume]

17071

119728

1.09

8.42

31.8

16.1

330.97

332.90

g/l

135.81

16928

118794

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1008

8803

0.82

8.40

1.8

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.02

8.36

1.1

—

(3016879) Cocaine [Presence] in Urine

296

3034

0.70

8.23

2.5

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4992

33254

1.10

8.18

3.1

3.0

0.78

0.77

ug/l

0.14

3535

22261

(3045424) Erythrocytes [Presence] in Urine

439

2350

1.35

8.09

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.00

8.09

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

477

4526

0.76

8.08

2.1

1.4

4.33

3.90

mg/l

0.32

345

3242

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

125

510

1.77

8.01

1.1

1635.12

1518.13

miu/ml

0.56

125

510

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

194

890

1.58

8.00

2.3

2.8

0.20

0.25

e9/l

3.05

171

783

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

180

2.33

7.81

1.7

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

343

1.94

7.81

2.3

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

173

778

1.61

7.76

2.7

2.8

39.58

37.28

0.82

117

416

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

188

2075

0.65

7.73

1.4

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

327

1681

1.41

7.73

1.4

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

370

1.89

7.71

2.3

2.0

43.52

35.75

u/l

0.15

334

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

567

1.71

7.60

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

567

1.71

7.60

1.6

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

223

2.14

7.31

1.5

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

574

1.69

7.29

1.6

2.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

173

2.30

7.22

1.2

1.3

90.51

153.33

ng/l

0.67

118

(4146454) Self-monitoring of blood glucose

333

1739

1.39

7.22

2.9

2.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

216

2.14

7.12

1.3

1.5

55.38

169.97

titre

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

377

1.84

7.02

1.7

1.6

10.04

9.11

ug/l

1.12

377

(3009871) Measles virus Ab [Titer] in Serum

389

1.82

6.94

1.5

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

443

4147

0.77

6.86

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

230

2.07

6.79

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1199

0.58

6.74

1.4

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

209

1020

1.48

6.58

2.3

2.7

622.07

699.15

e6/l

0.46

195

986

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

383

2082

1.33

6.48

2.5

2.7

231.42

1014.63

u/ml

1.32

374

2063

(3033923) Metanephrine [Moles/time] in 24 hour Urine

240

2.02

6.44

1.2

1.1

0.61

0.96

umol/24h

0.58

105

(3006922) Hepatitis E virus Ab [Presence] in Serum

183

875

1.51

6.38

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

297

1.90

6.32

1.2

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.92

6.16

2.9

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

221

1107

1.44

6.13

1.9

2.0

2.04

2.47

u/field

0.32

445

(3043238) Trisomy 21 risk [Likelihood] in Fetus

937

0.55

6.12

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

250

2499

0.72

6.12

2.5

2.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

158

739

1.55

6.11

1.7

1.9

1.42

2.88

u/field

2.47

108

518

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

247

1.96

5.98

1.1

1.2

—

(3019174) dRVVT (LA screen)

2.65

5.87

1.1

—

(3006462) Nitrate [Presence] in Urine

145

672

1.56

5.86

4.5

3.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1115

0.59

5.82

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

912

0.55

5.80

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1114

0.59

5.80

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1114

0.59

5.80

1.4

—

(3005033) Fetal Nuchal fold Thickness US

909

0.55

5.74

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1110

0.60

5.72

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

272

1.89

5.69

1.6

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

2.56

5.67

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

193

958

1.46

5.65

1.1

304.86

281.77

mg/l

3.84

173

863

(3027923) C peptide [Moles/volume] in Serum or Plasma

158

753

1.52

5.65

1.4

1.20

nmol/l

0.03

126

580

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

106

2.45

5.53

1.3

0.86

1.32

ml/s/173m2

1.29

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

922

5648

1.18

5.50

2.9

3.7

546.70

1366.90

u/ml

1.84

761

4888

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

108

474

1.65

5.48

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

894

1.46

5.46

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

900

1.46

5.45

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

943

7954

0.85

5.44

1.7

1.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

308

1.81

5.42

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

308

1.81

5.42

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

308

1.81

5.42

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

308

1.81

5.42

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

177

2.08

5.39

1.3

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

356

3314

0.77

5.38

1.8

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

244

1277

1.38

5.35

1.7

1.4

26.63

22.69

iu/ml

0.32

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

180

895

1.45

5.26

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

391

2199

1.29

5.26

1.5

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

452

1.65

5.25

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

12.99

5.18

1.0

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

179

894

1.45

5.13

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

180

900

1.45

5.12

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

158

770

1.48

5.12

1.7

1.4

7.14

5.94

u/l

0.44

128

648

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

249

1319

1.37

5.09

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

168

831

1.46

5.06

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

179

900

1.44

4.96

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

162

800

1.46

4.94

1.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

192

980

1.42

4.91

3.7

3.6

314.99

129.17

nmol/l

2.73

187

969

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

345

1.72

4.91

1.4

1.3

32.12

40.05

1.13

225

(3020717) Zinc [Moles/volume] in Serum or Plasma

123

575

1.55

4.87

1.3

1.6

19.51

27.17

umol/l

2.30

114

545

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

162

803

1.46

4.85

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

166

827

1.45

4.84

1.3

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

249

2387

0.75

4.73

3.4

3.6

37.78

44.35

u/ml

0.23

238

2327

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

172

2.01

4.71

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

480

2806

1.24

4.71

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

101

1134

0.64

4.70

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

377

1.67

4.70

1.6

—

(3025130) Human papilloma virus identified in Specimen

124

1334

0.67

4.69

1.4

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2180

14312

1.11

4.68

1.5

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.19

4.68

1.0

5.62

5.11

mmol/l

0.39

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

324

1.72

4.63

1.1

1.2

385.57

250.23

pmol/l

1.05

236

(3006245) CD3-CD19+ cells/100 cells in Blood

107

491

1.57

4.61

2.3

2.4

10.70

10.80

0.03

449

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

553

3290

1.22

4.60

1.1

9.33

7.60

u/ml

0.22

374

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

202

1054

1.39

4.58

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

546

3246

1.22

4.57

1.2

1.1

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

+∞

4.57

1.2

0.0

184.40

—

ug/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

116

1257

0.66

4.57

1.4

1.3

149.34

177.39

pmol/l

1.49

116

1257

(3011288) Drugs identified in Urine by Screen method

216

2101

0.74

4.56

3.9

2.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

353

1.68

4.55

1.8

1.5

0.36

0.38

ug/l

0.19

227

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

134

649

1.49

4.53

2.1

2.2

112.12

116.89

ug/min

0.03

150

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

343

1.68

4.51

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

582

3490

1.21

4.48

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

131

1380

0.68

4.47

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

2.25

4.41

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

105

488

1.55

4.31

2.2

2.3

29.42

29.44

0.01

459

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

570

3429

1.20

4.26

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

206

1093

1.36

4.25

1.2

—

(36660697) Celiac disease serology panel - Serum

1580

10250

1.12

4.25

1.2

—

(3024263) Appearance of Synovial fluid

142

708

1.45

4.19

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

269

1.74

4.18

1.6

2.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.15

4.12

1.0

1.2

1.00

1.64

u/field

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.51

4.09

1.0

1.1

1.00

1.08

u/field

0.33

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

855

5352

1.16

4.00

1.1

11.44

2.93

u/ml

0.41

(3018291) Platelet Ab [Presence] in Serum

4.81

3.96

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

417

3666

0.82

3.93

1.4

29.27

30.82

iu/l

0.39

347

3072

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

644

0.57

3.92

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

106

2.18

3.89

2.8

2.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

696

0.59

3.87

12.2

12.3

0.63

0.64

mmol/l

0.12

633

(3017315) Amylase [Enzymatic activity/volume] in Urine

144

732

1.42

3.87

1.3

1.2

241.17

393.84

u/l

1.46

133

680

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.47

3.85

1.3

1.5

—

(3022621) pH of Urine by Test strip

1426

9257

1.12

3.82

3.5

2.9

—

(44813793) Dust mix specific IgE antibody measurement

166

867

1.38

3.82

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

327

1.63

3.79

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

240

1.74

3.77

1.2

126.21

36.21

mg/l

0.43

189

(3026470) Cobalt [Mass/volume] in Blood

189

1012

1.35

3.74

2.0

1.9

3.42

3.29

ug/l

0.12

178

928

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

312

1789

1.26

3.73

3.8

3.4

16.12

8.65

nmol/l

0.75

299

1748

(3014051) Protein [Presence] in Urine by Test strip

590

3610

1.18

3.71

3.1

2.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

473

1.51

3.66

1.7

1.4

2427400.00

1568346.19

iu/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

140

1401

0.72

3.64

1.0

1.1

2.36

3.98

u/ml

1.38

655

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.34

3.60

1.8

1.7

1.66

1.22

mg/l

0.17

(3025577) Chromium [Mass/volume] in Blood

182

977

1.35

3.56

2.1

2.0

2.23

2.31

ug/l

0.14

159

816

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

107

524

1.47

3.53

1.7

2.0

74.37

142.95

umol/l

3.70

281

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

147

764

1.39

3.52

1.1

10.03

7.66

nmol/l

0.17

142

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

574

1.45

3.45

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

177

1688

0.75

3.38

1.0

1.1

1.19

1.56

u/ml

0.37

865

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.31

3.36

1.7

2.66

3.67

mg/l

0.33

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.31

3.36

1.8

1.7

1.67

1.42

mg/l

0.10

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.31

3.36

1.7

0.73

1.31

mg/l

0.42

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.31

3.36

1.8

1.7

4.11

4.12

mg/l

0.00

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.31

3.36

1.7

0.83

1.68

mg/l

0.97

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.31

3.36

1.8

1.7

5.01

2.19

mg/l

0.68

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.31

3.36

1.8

1.7

1.74

1.69

mg/l

0.01

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.31

3.36

1.7

2.33

0.79

mg/l

0.46

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.31

3.36

1.8

1.7

1.63

1.78

mg/l

0.07

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.19

3.36

3.4

2.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

260

1.67

3.35

1.5

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

433

3728

0.83

3.34

1.4

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

355

2095

1.23

3.32

1.5

1.6

—

(40768441) Liver Pathology biopsy report

196

1077

1.32

3.30

1.5

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

484

0.55

3.30

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.41

3.22

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

109

547

1.44

3.21

2.1

2.4

46.90

52.44

umol/l

0.93

458

(40768800) Prostate Pathology biopsy report

466

3969

0.84

3.19

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

430

1.49

3.17

2.4

3.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

159

855

1.34

3.13

1.3

2.01

1.66

u/ml

0.17

497

(3023430) Cat dander IgE Ab [Units/volume] in Serum

134

1314

0.73

3.13

1.1

2.75

4.84

u/ml

1.35

529

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.22

3.10

6.1

5.1

—

(40765096) Chromosome analysis panel by Banding

427

1.49

3.09

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

116

1159

0.72

3.06

1.0

0.23

0.51

u/ml

0.85

357

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.69

3.03

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1189

7752

1.11

3.02

1.2

117.35

142.74

iu/ml

1.44

398

2837

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

274

1.61

3.01

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

315

1.56

2.96

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

199

1.70

2.90

1.4

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

100

1011

0.71

2.86

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

106

1.97

2.83

1.0

1.3

9.49

17.47

pmol/l

0.81

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.11

2.78

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

117

614

1.38

2.74

1.4

1.2

63.86

62.87

0.04

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

213

1218

1.26

2.72

1.3

1.48

1.39

nmol/l

0.62

188

1104

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

232

1.62

2.67

1.0

—

(3020491) Glucose [Moles/volume] in Blood

174

974

1.29

2.64

1.5

1.9

7.28

6.88

mmol/l

0.91

117

682

(3009015) Lactate [Moles/volume] in Synovial fluid

156

1.76

2.64

1.3

6.02

6.25

mmol/l

0.09

(3006969) Lambda light chains [Mass/volume] in Urine

2.99

2.56

1.1

1.0

0.01

0.03

g/l

—

(4035726) Immunohistochemistry procedure

2033

13693

1.08

2.55

1.5

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

106

1.91

2.51

1.1

1.2

1.64

1.76

umol/24h

0.27

106

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.28

2.44

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

117

628

1.35

2.42

1.8

1.5

9.09

8.37

ug/l

0.22

106

575

(3020191) Ethanol [Moles/volume] in Serum or Plasma

186

1064

1.26

2.41

1.4

1.09

1.39

promille

1.77

130

827

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

104

1010

0.74

2.37

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.91

2.37

1.7

50.81

41.48

umol/l

0.60

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.94

2.36

1.4

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.85

2.36

3.5

3.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

181

1036

1.26

2.35

2.4

2.5

17.21

17.55

nmol/l

0.18

171

990

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.41

2.35

1.1

197.43

184.44

pmol/l

—

(3023410) Appearance of Cerebral spinal fluid

158

1448

0.79

2.34

1.7

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.42

2.34

5.4

1.5

5.21

1.64

mu/l

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.71

2.34

1.3

1.0

0.03

0.37

g/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

128

1203

0.77

2.32

1.0

320.93

331.63

ng/l

0.19

839

(3034274) Bile acid [Moles/volume] in Serum --fasting

158

892

1.28

2.30

1.8

2.1

14.23

9.94

umol/l

0.54

114

655

(3015076) Soybean IgE Ab [Units/volume] in Serum

574

0.67

2.28

1.1

1.0

0.29

1.99

u/ml

1.11

176

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

928

0.74

2.27

1.8

1.7

—

(40768795) Lymph node Pathology biopsy report

245

1456

1.22

2.27

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

108

580

1.34

2.25

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

476

0.64

2.25

2.5

155.35

151.93

nmol/l

0.05

409

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

775

0.72

2.23

1.4

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

177

1018

1.26

2.23

1.2

8.71

9.02

mmol/l

0.44

168

969

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.81

2.21

1.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

907

0.74

2.21

1.6

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

199

1.60

2.20

1.5

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

294

1.47

2.12

1.2

94.06

58.15

mu/l

0.71

222

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

1210

0.78

2.11

1.0

43.37

42.34

ng/l

0.11

834

(1002224) Polysomnography panel

638

5140

0.89

2.10

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

131

1207

0.78

2.07

1.0

758.65

730.73

ng/l

0.25

813

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.06

2.03

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.02

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

158

1418

0.80

2.01

2.9

2.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

363

0.62

1.96

1.5

2.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

114

0.38

1.93

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

183

1078

1.23

1.91

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

609

3941

1.12

1.90

1.8

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1416

9528

1.08

1.90

2.5

2.4

26.74

24.97

au/ml

0.19

698

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

407

2570

1.14

1.89

1.3

161.81

213.22

miu/ml

2.07

134

1082

(1761868) Lipid panel - Serum or Plasma

6566

48700

0.96

1.87

3.5

2.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

284

1750

1.17

1.84

1.1

—

(3007463) Buprenorphine [Presence] in Urine

2.71

1.83

10.4

5.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1286

8636

1.08

1.83

1.3

65.76

56.30

au/ml

0.56

484

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

408

1.36

1.82

1.3

1.2

32.64

19.58

0.68

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

746

0.74

1.82

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

353

1.39

1.81

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

367

1.38

1.77

2.4

143.14

957.89

e6/l

0.74

209

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.40

1.75

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

251

2122

0.85

1.74

1.1

3.12

1.79

u/ml

0.70

123

1118

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

132

0.44

1.72

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.75

1.71

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

105

1.72

1.70

4.8

6.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

967

6446

1.09

1.68

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

366

0.65

1.68

1.9

1.8

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.33

1.66

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

382

3120

0.88

1.65

1.9

1.7

322.27

293.88

mu/l

0.87

344

2853

(3038177) Helicobacter pylori Ab [Presence] in Serum

320

2015

1.15

1.60

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

158

1.55

1.59

1.3

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

172

0.50

1.59

2.7

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.71

1.56

1.4

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

194

1.49

1.56

1.1

1.3

43.78

46.50

mg/l

0.13

161

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

765

1.24

1.55

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

541

4307

0.90

1.52

1.8

1.7

45.91

41.97

nmol/l

3.30

518

4186

(40768793) Breast Pathology biopsy report

372

3022

0.89

1.51

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

280

1.39

1.50

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

274

1.40

1.50

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

303

0.64

1.49

2.2

3.0

182.95

113.42

ng/l

0.54

137

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

204

0.57

1.47

1.2

48.52

68.76

u/ml

1.06

195

(3003888) Timothy IgE Ab [Units/volume] in Serum

227

1903

0.86

1.47

1.1

5.97

4.26

u/ml

0.68

982

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.98

1.47

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

107

616

1.25

1.45

1.2

1.1

740.22

746.15

ng/l

0.00

141

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

176

1067

1.19

1.45

1.4

1.3

2.23

2.14

mmol/l

0.39

161

993

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.28

1.43

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

198

1.46

1.43

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

439

1.30

1.42

2.3

3.0

1.50

1.11

ug/l

0.69

417

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

100

1.66

1.42

1.1

8.96

10.04

u/l

0.14

100

(3011325) HIV 1+2 Ab [Presence] in Serum

1.94

1.40

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

1.40

13.1

7.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

220

1839

0.86

1.39

1.0

1.1

1.01

1.09

u/ml

0.09

819

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

269

2215

0.87

1.38

1.1

76.98

5234.75

iu/ml

0.56

466

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

182

1.47

1.38

1.4

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

310

1.35

1.37

1.2

17.79

16.65

umol/l

1.23

276

(4212803) Bone marrow aspirate examination

130

1.55

1.35

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1036

6997

1.07

1.34

1.7

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

246

2033

0.87

1.34

4.1

4.9

358.28

364.50

umol/l

0.31

214

1725

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

202

1250

1.17

1.33

1.4

1.3

33.56

29.45

u/l

0.87

164

1026

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

708

0.78

1.32

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.31

1.26

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

185

0.58

1.26

4.6

2.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.66

1.25

3.6

5.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

145

1.49

1.24

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

184

0.59

1.23

9.2

5.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

151

1.48

1.23

3.0

2.7

0.95

1.34

mg/l

0.89

107

(3035933) Granulocytes/100 leukocytes in Blood

357

0.71

1.23

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

454

2977

1.10

1.22

1.9

1.8

0.92

0.77

nmol/l

2.92

377

2491

(40762887) Creatinine [Moles/volume] in Blood

2.22

1.22

1.1

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

117

1.54

1.19

1.2

1.3

1059.30

206.52

mg/24h

—

(3018133) Calcium [Moles/volume] in Urine

250

1.36

1.18

1.9

2.2

2.49

2.57

mmol/l

0.08

224

(3011897) Casein IgE Ab [Units/volume] in Serum

172

0.59

1.17

1.0

1.3

0.04

1.82

u/ml

2.83

172

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

165

1.44

1.17

2.3

2.9

0.73

0.52

u/field

0.51

165

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

285

0.68

1.16

1.4

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.84

1.14

1.2

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.40

1.14

1.0

2648.57

1841.90

titre

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

152

0.57

1.13

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

123

743

1.20

1.12

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

287

1850

1.12

1.10

1.1

9.65

12.84

au/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

100

595

1.21

1.08

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

1710

1.12

1.07

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

211

1728

0.88

1.06

1.2

7.45

7.47

mmol/l

0.02

185

1476

(3009992) Blasts/100 cells in Bone marrow

2.40

1.06

1.8

1.5

17.60

13.93

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2058

15428

0.96

1.05

1.7

1.8

1.61

1.49

7.26

1719

13429

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.64

1.04

1.2

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.10

1.03

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.46

1.03

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

170

1.40

1.02

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

129

0.56

1.02

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.91

1.01

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

359

1.27

1.01

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

535

1.21

1.00

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

1.00

0.0

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.86

0.98

1.8

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

367

1.26

0.98

1.2

1.3

105.94

129.08

nmol/l

1.07

252

(3029396) Erythrocyte agglutination [Presence] in Blood

154

0.61

0.98

2.5

2.7

—

(3024869) Neuronal Ab [Presence] in Serum

285

1.29

0.96

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.51

0.96

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

153

0.61

0.95

15.1

1.3

8.12

7.16

mmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

305

0.73

0.94

5.6

6.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

211

1.33

0.93

1.9

1.8

91.00

49.03

pmol/l

0.64

175

(3014599) Egg white IgE Ab [Units/volume] in Serum

658

0.82

0.92

1.1

3.12

6.64

u/ml

0.36

188

(3023511) Choriogonadotropin [Units/volume] in Urine

117

986

0.86

0.92

1.4

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.55

0.91

1.2

1.5

13.43

20.55

pmol/l

0.95

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.73

0.90

3.6

4.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.73

0.90

1.0

1.2

218.03

321.03

nmol/l

1.26

(3012494) Peanut IgE Ab [Units/volume] in Serum

314

1.26

0.90

1.1

0.82

15.85

u/ml

0.79

177

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

477

1.21

0.89

1.3

2.81

3.84

umol/l

2.86

439

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

213

1371

1.12

0.89

1.5

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

153

964

1.15

0.89

2.8

2.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.76

0.88

1.2

1.4

364.97

621.15

nmol/l

0.81

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.86

0.87

4.5

5.9

—

(4281824) Cell count and differential, peritoneal fluid

240

1558

1.11

0.87

1.3

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.56

0.84

1.0

1.1

59.81

161.71

u/l

0.55

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.51

0.83

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.51

0.83

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

397

1.22

0.81

1.2

1.7

—

616.20

iu/ml

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.66

0.81

3.8

4.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.79

0.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.62

0.79

1.1

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

173

1.33

0.79

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

606

0.83

0.78

1.4

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

229

1495

1.11

0.77

1.8

1.9

840.00

2571.14

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

407

1.21

0.76

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

296

1.24

0.76

2.5

2.3

2.93

3.92

ug/l

1.11

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

103

858

0.87

0.74

1.3

1.53

1.55

g/l

0.19

103

858

(3016244) Insulin [Units/volume] in Serum or Plasma

108

676

1.15

0.73

2.9

3.2

32.68

25.51

mu/l

0.59

636

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

784

1.14

0.73

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

120

1.38

0.71

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

574

0.84

0.69

1.7

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

384

2970

0.93

0.69

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

346

1.21

0.69

2.0

2.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.39

0.68

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

317

2118

1.08

0.67

2.1

2.2

3068.75

4544.30

u/l

0.44

777

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.64

0.65

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.46

0.63

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

308

0.80

0.62

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

200

1.26

0.62

1.1

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

1.28

0.60

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

106

1.36

0.59

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

200

0.76

0.58

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

1.41

0.57

3.5

2.4

—

(3002619) Bacteria identified in Specimen by Culture

282

1.20

0.56

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.37

0.55

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

383

1.17

0.54

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

122

791

1.11

0.53

1.0

1.1

11.20

9.66

iu/ml

0.32

172

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.42

0.53

1.1

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.55

0.53

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.47

0.52

1.7

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

879

6579

0.96

0.52

3.1

4.1

44.31

64.86

u/ml

2.05

831

6360

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

200

1.23

0.50

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

200

1.23

0.50

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

684

0.89

0.50

1.3

1.6

2.80

5.30

ug/l

2.12

525

(3020874) Milk IgE Ab [Units/volume] in Serum

675

0.89

0.48

1.1

0.59

2.20

u/ml

1.86

246

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

175

1.24

0.48

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

362

1.16

0.47

1.1

—

(3001729) Color of Synovial fluid

111

1.30

0.47

1.7

1.6

—

(3006598) pH of Arterial cord blood

0.68

0.46

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

176

1.23

0.46

9.2

7.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

573

1.12

0.46

1.0

1.1

4.18

8.16

u/ml

1.14

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

793

0.90

0.46

1.5

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.34

0.45

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

114

746

1.10

0.45

1.2

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

458

3156

1.05

0.43

1.3

1.4

3.87

3.79

mmol/l

0.85

427

2974

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

224

1.19

0.43

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.40

0.42

1.6

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.57

0.42

1.2

1.3

1.32

2.59

mmol/24h

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.41

0.42

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.42

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.42

0.0

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

204

1574

0.93

0.42

1.6

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.37

0.41

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

384

0.86

0.41

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

772

0.91

0.41

4.1

5.6

44.00

5539.10

u/ml

—

146

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

103

675

1.10

0.41

1.0

1.1

1.16

1.12

u/l

0.23

338

(3003577) Lead [Moles/volume] in Blood

1.29

0.39

1.1

1.3

0.10

0.20

umol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

139

927

1.08

0.38

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

174

1344

0.93

0.38

1.8

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.41

0.38

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

204

1381

1.07

0.38

3.3

2.9

88.58

32.05

mg/l

1.26

155

979

(3025018) Bordetella pertussis Ab [Titer] in Serum

108

713

1.09

0.38

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

181

1.20

0.37

1.6

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

365

1.13

0.35

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

156

1.20

0.35

1.5

2.7

1.11

1.58

mmol/l

0.61

111

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

208

1589

0.94

0.34

1.1

2.72

3.54

u/ml

0.61

672

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

331

0.87

0.34

1.2

—

(3008898) HLA-B27 [Presence]

501

3740

0.97

0.32

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.36

0.31

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

480

0.90

0.31

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.24

0.29

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

351

1.11

0.28

1.5

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.30

0.27

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

895

1.06

0.27

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

311

1.11

0.27

1.5

1.7

185.48

125.14

au/ml

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

195

1.15

0.26

2.5

1.3

—

(3013862) HLA-DP [Type]

0.69

0.26

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

128

1.18

0.26

1.0

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

138

940

1.06

0.25

1.1

296.38

298.35

mg/l

0.03

120

832

(3022475) Manganese [Moles/volume] in Blood

0.78

0.25

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

313

1.11

0.25

1.2

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

202

1392

1.05

0.25

1.1

—

78.32

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

850

1.06

0.24

5.6

6.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

449

3145

1.03

0.24

1.5

1.4

12.25

9.58

u/l

3.09

359

2512

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

215

0.87

0.24

1.8

2.1

15.21

17.85

umol/l

0.72

215

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2763

19714

1.01

0.24

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

1.15

0.24

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.23

0.23

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

180

1240

1.05

0.23

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.29

0.23

1.2

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

394

0.92

0.22

1.3

1.2

104.25

113.06

1.28

349

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

981

1.05

0.22

1.1

46.38

44.64

mg/l

0.14

113

835

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

24.78

—

(40758358) Immune stain study

0.77

0.21

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

400

0.92

0.21

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

179

1.13

0.20

1.8

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

189

0.88

0.20

1.6

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.24

0.20

1.0

159.83

161.89

g/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.81

0.20

1.5

1.3

267.50

346.36

umol/24h

—

(3036180) Methadone [Presence] in Urine

429

0.92

0.20

1.9

2.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.20

0.20

5.8

2.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

150

0.87

0.19

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

180

1.12

0.19

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

220

1642

0.97

0.18

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

264

1.09

0.18

1.0

8.46

12.66

u/ml

0.57

139

(3022689) Creatine [Moles/volume] in Urine

448

0.93

0.17

1.4

1.5

—

(40763590) HLA-DQ beta [Type]

0.72

0.17

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.72

0.17

1.0

—

(40760410) HLA-B [Type] by High resolution

0.72

0.17

1.0

—

(40760409) HLA-A [Type] by High resolution

0.72

0.17

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

307

1.08

0.17

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.18

0.17

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

110

0.85

0.16

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

204

1424

1.03

0.16

3.1

3.8

39.94

57.08

u/ml

1.38

197

1406

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

141

1.13

0.16

1.5

1.2

21.29

20.52

mmol/l

0.41

114

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

385

1.07

0.16

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

232

1.09

0.15

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.80

0.15

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

221

1640

0.97

0.14

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

184

1.10

0.14

2.0

1.5

0.16

0.18

nmol/l

0.19

125

(3051387) C reactive protein [Mass/volume] in Capillary blood

438

3216

0.98

0.13

4.6

3.0

28.57

27.59

mg/l

0.21

293

1948

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

412

0.95

0.12

2.8

3.6

6.50

7.44

mg/l

0.62

332

(3045683) HLA typing for celiac disease panel - Blood or Tissue

706

0.96

0.12

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

419

0.95

0.12

1.3

1.2

0.33

0.31

g/l

0.81

338

(3017509) Phencyclidine [Presence] in Urine

0.87

0.11

3.1

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

104

724

1.04

0.11

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

378

1.05

0.10

1.2

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.16

0.10

1.0

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.14

0.10

1.0

0.39

0.79

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

160

1.08

0.09

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

539

0.96

0.09

2.8

3.0

30.54

28.45

umol/l

0.95

413

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

506

3608

1.01

0.08

1.4

562.95

558.70

mg/l

0.06

486

3430

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

377

0.96

0.08

2.4

2.9

234.01

170.47

au/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

381

2712

1.01

0.08

1.4

134.04

171.38

pmol/l

1.53

371

2644

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

156

0.92

0.08

1.1

107.74

81.34

ug/l

1.21

120

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

112

1.09

0.08

1.2

1.3

21.50

15.54

nmol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

111

0.91

0.07

3.5

3.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

389

1.04

0.07

1.7

2.1

7.40

9.63

mg/l

2.67

316

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.03

0.07

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.09

0.07

1.2

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.10

0.07

1.1

1.6

19.29

10.08

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.89

0.06

1.1

1.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.88

0.06

1.3

1.2

1.29

1.37

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

384

1.03

0.06

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

114

1.08

0.05

1.7

2.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

1.08

0.05

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.10

0.05

1.1

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

167

0.95

0.04

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.91

0.04

3.2

3.7

—

0.00

—

(3032868) Hemoglobin electrophoresis panel in Blood

108

0.93

0.04

1.4

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

130

1.05

0.03

1.0

0.01

0.30

u/ml

0.81

(40765089) Chromosome analysis panel - Blood by G-banded

223

1.04

0.03

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

223

1.04

0.03

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1680

12089

1.00

0.03

2.1

12.42

12.85

nmol/l

1.31

1442

10842

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

427

3072

1.00

0.01

2.0

1.9

187.83

202.65

pmol/l

2.65

401

2903

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

178

0.97

0.01

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

147

1.03

0.00

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

165

1195

1.00

0.00

1.4

0.40

0.29

nmol/l

0.57

115

895

(3041672) Baker's yeast Ab [Presence] in Serum

1.06

0.00

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.01

0.00

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

143

1.01

0.00

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

228

1.01

0.00

1.1

1.4

54.79

54.66

0.00

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

121

1.01

0.00

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

273

1.00

0.00

1.6

1.8

2.26

2.69

ug/l

0.42

155

(3032352) Blasts [#/volume] in Cerebral spinal fluid

180

1.00

0.00

1.8

2.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

136

1.01

0.00

1.1

1.2

15.38

23.41

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

105

0.96

0.00

1.4

1.6

43.43

37.92

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

114

1.01

0.00

1.2

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

436

3141

1.00

0.00

1.4

1.5

55.46

27.48

e6/l

0.47

357

2425

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

646

0.99

0.00

1.2

1.3

5.96

6.02

mmol/l

0.18

614

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

166

1201

1.00

0.00

4.5

5.1

103.63

122.31

u/ml

0.11

367

(3020650) Glucose [Presence] in Urine

340

1.00

0.00

1.3

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

436

3147

1.00

0.00

1.5

1.6

2475.16

3112.00

e6/l

0.14

373

2542

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.00

0.00

1.0

1.1

—

(3013762) Body weight Measured

0.92

-0.00

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.97

-0.00

1.0

1.2

—

mmol/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.84

-0.00

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.00

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_NONRHEVALV and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_NONRHEVALV	1.736 [1.59, 1.89]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.055

During the follow-up period (1.1.1998 — 31.12.2019), 31028 out of 80329 females with I9_NONRHEVALV died.

Males

Parameter	HR [95% CI]	p-value
I9_NONRHEVALV	1.699 [1.55, 1.87]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 28903 out of 78811 males with I9_NONRHEVALV died.

Mortality risk

Mortality risk for people of age

years, who have I9_NONRHEVALV.

N-year risk	Females	Males
1	0.163%	0.268%
5	0.874%	1.582%
10	2.138%	3.94%
15	4.021%	7.365%
20	6.991%	12.656%

Relationships between endpoints

↥

Index endpoint: I9_NONRHEVALV – Non-rheumatic valve diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Non-rheumatic valve diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints